Production V6 9.26.20

PRODUCTION HEALTH & SAFETY GUIDELINES

During The COVID-19 Pandemic V6 9.26.20

BATTLEBOTS – SEASON 5

TABLE OF CONTENTS

GENERAL OVERVIEW & PRINCIPLES 3 SOCIAL DISTANCING 4 TESTING PROCEDURES 5 CAST AND CREW TRAVELING TO LOCATION 5 ARRIVAL ON LOCATION 5 DURING THE SHOOT 5 SYMPTOMATIC INDIVIDUALS 6 CONFIRMED POSITIVE QUARANTINE 7 FUNCTIONING GROUPS AND ZONES 8 FUNCTIONING GROUPS 8 ZONES 9 PERSONAL PROTECTIVE EQUIPMENTS (PPE) 9 FACE COVERINGS 9 GLOVES 10 AIR EXCHANGE 10 ENHANCED SANITIZATION PROCEDURES 11 MEALS, CRAFT SERVICES AND OTHER SUPPLIES 12 COVID-19 SAFETY DEPARTMENT 12 SYMPTOM MONITORING 13 SOCIAL RESPONSIBILITY PLEDGE 14 BOT BUILDER PROCEDURES 14 TRAVEL TO LOCATION 14 INSPECTION PROCESS 16 REPAIR PROCESS 17 FIGHT PROCESS 18 INTERVIEW PROCESS 19 FOOD, SUPPLIES, BREAKS & DELIVERIES 20 PPE REQUIREMENTS 20 COMMUNICATIONS 21 MINORS 21 RESTROOMS 22 INSURANCE 22 APPENDIX A – SOCIAL RESPONSIBILITY PLEDGE 24 APPENDIX B – BOEING HANGAR 52 SITE PLAN 25 - 26 APPENDIX C – PCR TEST PROCESS AND DATA SHEET 27 - 41 APPENDIX D – HEALTH SCREENING APP 42 APPENDIX E – AIR EXCHANGE ENGINEERING REPORT 43 - 74 APPENDIX F – COVID-19 CDC INFORMATION 75 - 90

GENERAL OVERVIEW & PRINCIPLES

The Film & Television industry has been severely impacted by the COVID-19 pandemic, raising new concerns about health & safety practices for the resumption of filming activity across the industry. Greetings Media and BattleBots Inc. (collectively referred to herein as “Production”) have been diligently working with the unions and local authorities on new practices and protocols in order to provide a safe production environment for all individuals involved. These new guidelines are based on best practices outlined by a number of local, State and Federal governmental agencies as well as private organizations in the entertainment business. Particular emphasis was given to the guidelines provided by the U.S. Center of Disease Control (“CDC”), the Occupational Safety and Health Administration (“OSHA”), the Entertainment Union Joint Committees for Safety Guidelines (DGA, SAG-AFTRA, IATSE) and The Alliance of Motion Picture and Television Producers (“AMPTP”). Please note that these Production Health & Safety Guidelines may change as the facts related to COVID-19 and the guidelines and practices provided by the above organizations evolve. Production reserves the right to make changes to any material contained in these, and any future, Production Health & Safety Guidelines following, and consistent with, legal review.

The following principles were used as the foundation for these guidelines:

● The #1 priority at all times during the production is the health and safety of all Bot Builders, staff, crew, and any other individuals involved in the on-set production of BattleBots Season 5 (collectively referred to herein as “Cast and Crew”).

● Established medical expertise will guide decision making with respect to the implementation of these guidelines or any other protocols used to ensure Cast and Crew health and safety.

● Production operations will be designed to allow Cast and Crew to adhere to social distancing guidelines. When social distancing is impracticable, other risk mitigating measures will be put in place as more fully described in this document (use of PPE, Plexiglass Dividers, etc.).

● Adequate amounts of the Personal Protection Equipment (“PPE”) will be made available along with instructions for its proper use.

● Diagnostic testing for COVID-19 is an essential element of these health and safety guidelines and will be required of all Cast and Crew.

● Daily symptom monitoring, including temperature screening and health questionnaires will be utilized to further mitigate risk.

● Systems for adequate air exchange will be implemented throughout the set to

mitigate the potential spread of aerosolized virus particles.

● Enhanced sanitation procedures will be implemented across the entirety of the set including the use of electrostatic disinfection sprayers, regular disinfection of high touch areas and equipment, and increased access to hand washing/disinfection stations.

● One or more dedicated COVID-19 Safety Supervisor(s) with specialized training will be on set to ensure the proper implementation and adherence of these COVID-19 health and safety guidelines and will be available to and address any other related issues as they arise.

● All applicable state, local, and federal (CDC) public health requirements will be followed.

*Note on nomenclature: to maintain consistency with public health and medical guidelines, COVID-19 refers to the name of clinical syndrome caused by the virus referred to as SARS-CoV-2.

SOCIAL DISTANCING

The CDC advises that limiting direct and/or close contact with others is the best way to reduce the spread of COVID-19. One of the most effective measures in accomplishing this task is through adherence to social distancing. Accordingly we are asking all individuals on set to adhere to the following social distancing guidelines:

● Maintaining a minimum distance of 6’ between you and other individuals on set is required whenever feasible.

● There are a number of specific circumstances identified within these guidelines that provide for exceptions to the social distancing requirement when 6’ social distancing is not possible. Separate precautions specific to the circumstance are to be taken as outlined herein.

● For events or circumstances that are not specifically identified as exceptions to the 6’ social distancing requirements but that do also not allow for individuals to maintain a 6’ distance apart, the following precautions are required:

○ Utilization of an approved face covering (as outlined in the PPE section below) as well as any other PPE that Production or the Health and Safety Supervisor deems necessary.

○ Time spent within 6’ of another individual is to be kept to a minimum (10 minutes or less) and generally should be limited to only the amount of time needed to complete the applicable task.

○ Enhanced sanitation procedures as outlined below should be followed.

TESTING PROCEDURES

We believe strategic testing for the presence of COVID-19 is critical to create a safe work environment for our Cast and Crew. Accordingly all Cast and Crew will be subject to the following Diagnostic testing procedures and guidelines.

CAST AND CREW TRAVELING TO LOCATION

❖ Test #1 - Prior to Travel

All Cast and Crew traveling from out of state or from in state via shared transportation (air, train, bus, etc.) must complete a CDC-based pre-screening protocol before final approval for travel. This will consist of a health and wellness questionnaire, as well as a COVID-19 nasopharyngeal test (or similar mouth swab test). Production will assist with outlining resources for free testing in local areas. In the event a free test is not available in a local area, Production will pre-approve and reimburse the testing fee. All cast and crew must provide evidence of a negative test result received within 48 hours of their estimated arrival time.

ARRIVAL ON LOCATION

❖ Test #2 – Arrival on Location

Upon initial arrival to set, all travelling or out-of-town Cast and Crew will be required to check-in at the Boeing Building 52 security gate as soon as possible, and perform an additional COVID-19 rapid diagnostic test for clearance. Note that for non-traveling Cast and Crew this will be their first test administered for the production, and production may be able to coordinate a local test location the day prior to them entering. The rapid testing results will be delivered within 60 minutes and final approval to enter the location will be issued to everyone with a negative result. In the event anyone tests positive COVID-19, the Safety Supervisor will be notified and the Symptomatic and Confirmed Positives action steps as outlined below will be followed. Additional rapid tests may be administered at the discretion of the COVID-19 Safety Department and local health authorities.

DURING THE SHOOT

❖ Additional Testing: On Set Testing Every 3 Days

Provided that Cast and Crew results to Tests #1 and #2 were both negative, then each member of the Cast and Crew will be additionally tested no less than every three days

5 that they remain working and/or otherwise actively involved in the on set production. Testing will occur on a scheduled rotation basis to avoid long test waiting periods and lines. A private 3rd party laboratory will provide all PCR-based test kits and qualified medical staffing to administer all testing and handle notification of results. (see PCR test data sheet - Appendix C)

❖ Positive Test Result Procedure & Rapid Testing Procedure

In the event that any test comes back positive, the following procedures will apply:

❖ Positive Rapid Test positive:

● In the event anyone in your pod tests positive on the Rapid Test upon arrival, all individuals in the pod will be required to clear two consecutive PCR-based tests in order to rule out the initial false-positive test.

❖ Positive PCR protocol:

● In the event anyone in your pod tests positive on any of the scheduled PCR-based tests, all individuals in the pod will be required to clear two consecutive PCR-based tests in order to rule out the initial false-positive test.

❖ Failure to clear both consecutive PCR-based tests:

● Due to recent State, City and Union guidelines, in the event anyone in your pod tests positive on any of the two consecutive PCR-based tests, we are required to quarantine all the individuals in the pod separately for 14 days. This will effectively disqualify the affected pod from the tournament.

*Please note: All testing results will comply with HIPPA regulations between the testing lab and each individual. All test result notifications will solely be sent to WRI Human Resources and handled with all privacy guidelines adhered to.

SYMPTOMATIC INDIVIDUALS

If a member of the Cast and Crew is feeling unwell and/or is symptomatic then the following procedure will be followed:

❖ Immediate Action ● The symptomatic individual should put on a mask if not already wearing one.

● The individual will be separated from the remainder of the production and transported to a quarantined testing facility.

● The remainder of the individual’s functioning group should put on masks if not already wearing them.

● The remainder of the individual’s functioning group will be separated and transported to a quarantined testing facility.

● The production’s COVID-19 Safety Supervisor will be informed.

● Clean and disinfect areas where the person and any close contacts were working and all places they have been. This may mean evacuating those areas. Use PPE when cleaning.

❖ Follow On Action ● The local health authorities will be informed and applicable local medical advice will be followed.

● The Rapid Testing procedures as outlined above will be administered to the symptomatic individual as well as the group.

● A series of rapid COVID-19 diagnostic tests will be administered to each group member pursuant to the Rapid Testing Procedure outlined above.

● Under the advice of local health authorities, Group members who test negative may be required to continue quarenting for follow up testing before returning to the set.

❖ Subsequent Action ● The Production will identify who at the workplace/location outside of the applicable functioning group had close contact with the symptomatic individual in the 48 hours before the person started to show symptoms and inform those Cast and Crew members they have been in contact with someone who is unwell. ● In consultation with the local health authority, the Production will determine those additional Cast and Crew members to undergo the Rapid Testing Procedures, if any.

CONFIRMED POSITIVE QUARANTINE

❖ Quarantine Arrangements

All members of the Cast and Crew who are confirmed positive with COVID-19 will be transported to a separate offsite quarantine facility (i.e one of a group of houses, hotel or apartments rented by Production for the purposes of quarantine) where they will stay until they can be safely returned home. Production will cover all costs related to room and board while an individual is in quarantine and cover the costs of the travel to safely return the individual home. While in quarantine Production will ensure the quarantined individual(s) has regular access to trained medical personnel in consultation with local

7 health authorities to ensure proper medical attention and quarantine procedures are being followed.

FUNCTIONING GROUPS AND ZONES

As all of you that have been involved in a previous season of BattleBots know, it is a big TV production combined with a big event which results in a constant beehive of activity across different working groups and areas of the set. In the past we have relied on cross functioning groups and individuals to bridge both communication and physical gaps on location. Under the current circumstances, we must implement a new approach to how the production and the event operate in terms of both functioning working groups and areas of the set. This is in order to better minimize the effect on all Cast and Crew in the event that one individual tests positive for COVID-19 during the production, and to provide for more effective contact tracing.

FUNCTIONING GROUPS

Accordingly, each member of the Cast and Crew will be assigned to a “functioning group” based on their required work location and/or their specific involvement with the production. These predefined groups will be assigned based on a number of factors including: an individual’s role on the production, the location where an individual will spend most of their time and the other individuals that they will be consistently interacting/working with on a daily basis. All Cast and Crew will be assigned a highly visible pass and/or wristband to be displayed at all times, which will help to clearly identify their functioning group.

As a result of this process, if a member of a group, following screening and approved entry into the set is identified as symptomatic or confirmed positive for COVID-19, additional steps recommended by medical personnel and/or the COVID-19 Safety Supervisor will be taken, including but not limited to, the re-testing of the entire functioning group and if necessary the removal and quarantine of the group.

Each member of the Cast and Crew will be provided the following information upon entering the set:

● Functioning group assignments and Screening Clearance Wristband ● Specific working spaces and arrangements ● Areas onsite where they are prohibited from entering (without pre-approval) ● Whom they may interact with and when ● Protocols for social distancing and PPE use ● Entry process when competitions begin ● Meal times and procedures for their functioning group ● Event schedule and overall site operating hours

Below is the current working model for defining functioning groups:

❖ Group A1: Bot Builders Group 1 ❖ Group A2: Bot Builders Group 2 ❖ Group A3: Bot Builders Group 3 ❖ Group A4: Bot Builders Group 4 ❖ Group B: Broadcast Talent ❖ Group C: Master Control Room ❖ Group D: Producing Team ❖ Group E: Front of House Operations ❖ Group F: Camera Department ❖ Group G: Audio Department ❖ Group H: Lighting Department ❖ Group I: Staging Department ❖ Group J: Art Department ❖ Group K: Safety Team ❖ Group L: Casting Department ❖ Group M: Wardrobe / Hair & Makeup Team ❖ Group N: Production Office ❖ Group O: Catering & Craft Services ❖ Group P: Builder Support Staff (incl Haas/Lincoln etc.) ❖ Group Q: Digital Support Staff (e.g. social media/photographer ❖ Group R: Janitorial Staff

*Please note: Final functioning group designations are subject to change to allow for any adjustments needed for safety and compliance.

ZONES

Each functioning group will be assigned specific zone(s) on set which they will be regularly operating within and have access to. This may include access to multiple zones for single groups and access to the same zone at different times for multiple groups (with proper disinfection procedures implemented between groups). The zones will be clearly marked based on the corresponding assignments of their functioning group and an event site map with all zones marked will be provided to everyone upon arrival.

PERSONAL PROTECTIVE EQUIPMENT (“PPE”)

FACE COVERINGS

❖ Face Coverings are required at all times for Cast and Crew

Production will require the use of face coverings/masks at all times when on set, except when not feasible as noted below (see PPE REQUIREMENTS Page 21). These will be provided by Production to all cast and crew at no cost and meet applicable regulatory guidelines (CDC, Public Health) as appropriate. Face coverings will be provided to all

9 individuals and should not be shared with others. Cast and Crew (other than on-camera crew) may bring and use their own face covering provided such face covering is approved for use by the Safety Supervisor prior to use. Some members of the cast may not be able to wear face coverings at all times while on the job site (e.g. during hair/makeup, on-camera, eating). As soon as it is feasible, those who are temporarily prevented by their job duties from wearing a face covering should resume wearing one (e.g. after hair/makeup completed, off-camera).

Bot Builders wishing to supply their own masks should purchase, KN-95 or minimum 3-ply cloth masks. Bandanas, gaiters or masks with exhaust valves will not be allowed for face covering. Other types of mask or alterations to any face coverings should be pre-approved by Covid Compliance Supervisor prior to arrival. Ill fitting or visibly dirty masks will be required to be replaced.

GLOVES

❖ Glove use is not recommended

The AMPTP recommends against universal glove use by all cast and crew. Gloves may lead to a false sense of security and may actually increase risk, particularly due to self-contamination while doffing. Instead, effective and frequent hand hygiene with soap and water or alcohol-based hand rub is essential, along with avoidance of touching the eyes, nose and mouth.

AIR EXCHANGE

To mitigate the potential aerosolization of virus particles, production will implement a number of air exchange systems and best practices throughout the venue.

THE BUILDING

Taking advantage of our venue’s extreme amount of air volume and readily available floor-to-ceiling hangar doors, Production, in cooperation with a certified and licensed air balance engineer, will utilize existing industrial ceiling exhaust fans, to optimize the air exchange rate and maximize fresh air circulation through the building. These systems will be employed in both the main stage in the pit area, and create an air exchange system for the purpose of removing potential aerosolized virus particles. (See Engineering Report - Appendix E).

THE BUILDER’S STAGE

The Builder’s Stage (the area directly in front of the BattleBox Arena where Bot Builders operate their robots during matches) will be modified this season. A series of air vents and appropriate ducting will blow fresh air up through the floor panels to allow for a

10 constant supply of fresh circulating air while teams are battling their robots. This will supplement the already existing air exchange system provided by the building itself.

ENHANCED SANITIZATION PROCEDURES

Given the potential concern about transmission of COVID-19 via contact, enhanced hand hygiene measures are critical. Hand washing stations with running water, soap and paper towels will be available and accessible in all working areas, and will be kept well-stocked and regularly disinfected to best avoid cross-contamination. There will be ample stations available to accommodate all cast and crew. Signage will be posted prominently with instructions on how to stop the spread of COVID-19, including hand hygiene and PPE instructions. Guidelines for hand sanitization are as follows:

● Cast and crew should avoid touching their eyes, nose, and mouth with unwashed hands.

● Cast and crew will be reminded upon arrival on hand hygiene practices (20 seconds of duration, scrubbing all surfaces).

● Regular production reminders will occur to facilitate a break for hand hygiene and high-touch surface wipe downs.

● Local and wide area cleaning and disinfection will occur regularly

● Hands should be washed or sanitized upon the following:

○ Arrival on set every day ○ After blowing one’s nose/coughing/sneezing ○ After using the restroom ○ Before and after eating or drinking ○ After handling shared equipment or objects ○ After cleaning or disinfecting equipment, tools or workspaces ○ At other appropriate times throughout the workday

Protocols to clean and disinfect surfaces and objects throughout the entire facility will be implemented in regular intervals. These protocols will include, but not be limited to:

rd Procuring the services of a specialist 3 party cleaning crew to regularly perform ● cleaning services for the duration of the shoot

● Requiring all cleaning crew to wear appropriate PPE

● Thorough disinfection of all areas and equipment on set with industrial electrostatic disinfectant sprayers daily

● Providing clear instructions on how to remove PPE carefully to avoid contamination of the wearer and surrounding area

● Cleaning all high-touch surfaces and areas

● Emptying all trash receptacles daily and removing any items deemed to be left behind

● Cleaning with cleaners approved by the CDC and/or EPA in accordance with the directions on the label

● Prohibiting the re-use of un-labeled generic containers (cups, plates), to avoid mistakenly using another person’s container. Disposable catering cups and plates will be provided for single-use and immediate disposal afterwards.

● Daily disinfection of all vehicles, equipment, headsets, walkies, and tools

MEALS, CRAFT SERVICES & OTHER SUPPLIES

❖ Food & Supply distribution will be screened and sanitized

Dedicated runners, who will not enter the location or have contact with on-site personnel, will make any grocery runs for other food, supplies and other essential production-related items or supplies. These items will be dropped off outside the security checkpoint entrance, where they will be sanitized before being picked up and distributed to the recipient as quickly as possible. The same process will apply for all supplies and materials delivered for the Bot Builders (McMaster-Carr, etc.).

An on-site caterer will provide meals, which will be individually packaged and distributed to functioning groups in specifically designated areas at specified times to prevent a ‘central pickup location’ that requires convergence. We will eliminate communal buffet-style food service. Catered meals can be ordered using our Health Screening App available here: https://bb.backtoset.app/ (see Appendix D).

Under certain circumstances meals can be delivered to set via delivery services (DoorDash), and will go through the same screening and sanitizing process. Craft service items will be individually packaged and distributed to each functioning group. Cast and Crew have the option to bring their own pre-packed meal, however under no circumstances are shared containers and/or shared open food containers to be used on set and in the event such items are found, they will be discarded immediately.

COVID-19 SAFETY DEPARTMENT

❖ A dedicated COVID-19 Safety Department will be created to supervise the overall operating procedures and production activities at all times.

A new dedicated safety department will be implemented, consisting of a certified COVID-19 Safety Supervisor, COVID-19 Safety Managers and a COVID-19 Medical Screening staff. This new department will oversee all aspects of compliance in regards

12 to these health and safety guidelines approved by the Long Beach Health Department, and will communicate directly with our assigned Long Beach Health Department Safety Officer. The department will monitor compliance to all guidelines including: social distancing, symptoms, disinfecting protocols, and PPE education. In addition, the Long Beach Health Department will require their official Safety Officer to monitor all activities daily and will oversee the new COVID-19 Safety Team and the 3rd party onsite testing medical staff, to ensure procedures and protocols are being strictly followed. All cast and crew will be reminded daily about proper hygiene, social distancing and proper PPE use during each day’s safety meeting upon arrival.

The COVID-19 Supervisor and Management Team will supervise all pit activities - in addition to the Long Beach Health Department Safety Officer, with dedicated medics for both the pit and stage areas. There will be a total of six Compliance Managers patrolling, a Compliance Supervisor, and four compliance cleaners (dedicated to each mens/womens restroom for both West and East pits). A separate dedicated screening medic team will be located at the entrance gate and/or pit entrance to facilitate the daily screening process, and will temperature check everyone who enters, providing them with a clearance credential/wristband each day. In the event that someone has symptoms or a fever, they must notify the COVID-19 Safety Supervisor and/or Manager immediately to get further guidance on how to appropriately respond to the symptoms.

SYMPTOM MONITORING

All Cast and Crew will be required to participate in daily symptom monitoring prior to arriving on set or workplace, as well as daily monitoring while on location. This monitoring includes a wellness questionnaire checklist and temperature check.

Procedures include but are not limited to:

● Cast and Crew will be required to complete a health screening questionnaire each morning prior to arrival on set. The questionnaire can be completed via the BattleBots Screening App available at: https://bb.backtoset.app/. Individual testing QR codes may also be uploaded to this screening app, as well as access to the catering menu for daily ordering (see Appendix D).

● Manual screening and non-touch temperature check at the entrance/security gate at the beginning and end of each day.

● Any Cast and Crew that have chronic symptoms similar to the symptoms of COVID-19 due to other medical conditions (e.g. cough due to asthma or allergies), should discuss this with their personal physician and, if applicable, inform and discuss with the Set Medic and COVID-19 Safety Supervisor.

● Cast or Crew with risk factors for COVID-19 (i.e. advance age, comorbidities such as chronic lung disease, immunocompromised) should consult with their physician to discuss the risks and benefits in participating in production.

SOCIAL RESPONSIBILITY PLEDGE

As much as we feel confident that these guidelines will succeed in keeping everyone safe and healthy, as with any set of recommendations, they only work if people follow them. That’s why we are asking everyone participating in the production to voluntarily sign a “Social Responsibility Pledge” (see Appendix A). The pledge is an explicit acknowledgement of your commitment to your health as well as the health of your fellow Cast and Crew. By signing this pledge you are agreeing to follow these guidelines and work together with other Cast and Crew to provide a safe and healthy production environment.

● All Cast and Crew will be required to sign the Social Responsibility Pledge before they will be allowed on-site.

● Any violations to the pledge, or to any of these guidelines will be addressed and discussed with the individual/s in order to rectify the issue. Individuals or groups of individuals that are unable and/or unwilling to adhere to safety guidelines may be removed from the premises to ensure safety for everyone else following the guidelines. Production will employ a 3-strikes you’re out policy towards violators.

● In addition to complying with all the terms in the Social Responsibility Pledge, and to ensure everyone’s safety, all Cast and Crew will be asked to follow these social distancing guidelines while away from set and/or at their hotel/Airbnb.

BOT BUILDERS’ PROCEDURES

TRAVEL TO LOCATION

Please see TESTING PROCEDURES section above (page 5)

❖ Unloading of Bots

All bots received via shipping will be unloaded and transported to each team’s designated pit area. The surfaces of the containers will be sanitized and wiped down prior to the Bot Builders’ arrival. For any bots that will be self-transported in a vehicle, and delivered to set directly, there will be a staggered arrival schedule and assigned time for each team to unload and transfer the bot to their pits to adhere to distancing measures.

❖ Pit Areas

The Pit will be strategically redesigned this season to provide ample distance for all the teams, and allow maximum airflow and air exchange throughout the entire 3.7-acre space. All available entrance and floor-to-ceiling hangar doors will be opened, allowing for increased ingress/egress and, with the use of ceiling exhaust fans, increase air exchange.

Each individual pit area will be arranged in a “U” shaped figure, with three tables forming a barrier, and ample space between each team. In addition, the overall layout of the entire pit area will be expanded and designated into two main separate zones: West Pit, South Pit.

All pit areas will be stocked with hand sanitizer and carefully disinfected at the end of each day, providing a clean environment for the teams when they arrive every morning. The process will consist of disinfecting wipe downs, and electrostatic disinfectant fogging systems. The Pit Staff will survey all teams in advance to assess any special considerations regarding tools and equipment that may be affected by the cleaning process, and all adjustments will be made accordingly. In addition, any further cleaning requirements requested by any team during the day, will be immediately addressed.

New Union guidelines as of 9/21 require that approved face coverings must be worn in the pit area at all times, and may only be removed for short periods for essential consumption (eating, drinking), or short interviews. There is ample private outdoor space available at the venue where you may remove your mask for a respite, eating, drinking, etc. so long as you are socially distant from others.

❖ Surrounding Walkways

Designated walkways have been designed to allow at least 6ft distancing for Bot Builders and cast and crew to navigate within the pit area. These walkways will be the only route for safety inspectors and the production cast and crew to approach the Bot Builders at a distance. Food and supplies will also be delivered via these walkways. Everyone will be required to wear appropriate PPE at all times within these designated walkways.

❖ Photography

The photography booth will be centrally located in close proximity to one of the large rollup doors, and only accessible via the walkways noted above. The Casting Team and Pit Staff will schedule staggered times for all team/bot photographs, and only 1 team will be allowed in the photography area at a time. PPE may be removed during the photo shoot, but must be reapplied when completed and exiting back into the PPE walkway. The photographer will always wear PPE and shoot from at least 6 ft. away at all times.

❖ Travel To And From Set

All Bot Builders will be required to travel to and from set within their given functioning group/team. Ride sharing with others outside of your team is not permitted, as close contact within vehicles can’t be avoided and increases risk of transmission. Should there be any ground transportation needs or concerns throughout the duration of the event, Production will facilitate and provide a solution.

❖ Hotels/Airbnbs

The host hotels provided by Production in long beach are implementing enhanced cleaning and sanitization protocols as follows:

● Increased sanitation stations throughout the hotel including Guest Services, Dining Services and public areas.

● Hand sanitizer stations added to check-in areas.

● Proper hand washing and safety procedures with new signage for all employees.

● Adequate sanitation schedules of the hotel lobby, food service locations, public areas and entrances.

● A dedicated laundry service will be provided to pickup and deliver at the hotel.

● Adequate use of PPE for staff members for front and back of the house.

● Bot Builders may rent Airbnbs.

INSPECTION PROCESS

❖ Internal Inspections

All Safety Inspectors will access each Bot Builder’s pit via the walkways noted above and maintain distance while communicating during the inspection. PPE must be worn by the Bot Builder teams during this inspection, and Safety Inspectors will wear PPE at all times throughout the day.

❖ Functional Inspections & Test Box

Test Boxes will be designated into separate zones to accommodate the West and East pits separately. Once each Bot Builder team is ready for Functional Testing, teams will be required to line up in a designated PPE walkway area near their Test Box, keeping 8 feet distance between each team. PPE will be required at all times for everyone involved during the Functional Inspection/Test Box process.

❖ Battery Charging Tent

Battery Charging Tents will be designated into separate zones to accommodate the West and East pits separately. Each Bot Builder team will have a designated battery charging area with subdivided tables tagged for each team. Disinfectant wipes will be available for each team to wipe down their areas as needed.

A limited number of teams will be allowed to enter the battery tent at a time, and always under supervision of the dedicated battery tent Safety Inspector. Safety Inspectors will wear PPE at all times. The Safety Inspector will monitor the batteries throughout the day and deal with any issues or fires, and will notify the affected team

16 immediately. Communication with teams will be via cell, text or app-based messaging (eg. Discord).

REPAIR PROCESS

❖ Lincoln Electric Welding Station

The Lincoln Electric welding station will be re-positioned this season to a central exterior location for both East & West Pits to access. Teams must line up 8 ft. apart and wear PPE, with only one team at a time allowed to enter. Teams will drop off repairs to a Lincoln Electric clerk, who will be positioned behind a barrier for added protection during communications. Once repairs are completed, either a Lincoln Electric personnel or Pit Staff will inform the team the part is ready for pickup. Communication with teams will be via cell, text or app-based messaging (i.e. Discord).

❖ Machine Shop

The Machine Shop will be set up in a central interior location for both East & West Pits to access. Teams must line up 8 ft. apart and wear PPE. Teams can only enter this cordoned off space once a machine is available. Teams may be expected to do their own machining and clean up. Technicians will be available on site wearing PPE and positioned behind a Plexiglas barrier to answer questions and provide assistance. Note: Large tools brought by the Bot Builders may also be set up in this area with prior approval from Production.

❖ Paint Areas

The paint areas will be divided into two designated exterior areas for East & West Pits to access. Two 10x10 drop cloths will be provided for each area, and positioned at least 15 ft. apart. Teams must line up 8 ft. apart and can only enter the paint area when a space becomes available.

❖ Grinding Areas

The grinding areas will be divided into two designated exterior areas, and centrally located for East & West Pits to access. Each grinding area will have multiple zones divided with partitions to allow multiple Bot Builders to work at the same time, within distancing guidelines. Teams must line up 8 ft. apart while the grinding areas are in full use, and can only enter once a zone becomes available.

*Note: Numerous references have been made with regard to teams lining up in various areas and maintaining proper distancing. All references and areas mentioned will be clearly demarcated with visible markers on the floor. A limited number of teams will be allowed to line up at any given time. Teams should send one member of their pit crew to see if a space is available in any given line. Designated Pit Crew will be assigned to monitor lines to ensure proper distancing.

FIGHT PROCESS

❖ Fight Schedule Announcements

Fight schedule announcements will now be presented via a dedicated Discord Messaging server that all Team Captains will have access to. There will no longer be large gatherings, as Bot Builders will be able to receive all the information from their individual pit areas.

❖ Fight Viewing Boxes

As in previous seasons, the Casting Team and Pit Staff will manage Pre-Fight queuing. However, each bot building team in the queue will now have their own separate Fight Viewing Box. Think of these like opera boxes or arena suites. These boxes will be strategically arranged to ensure proper distancing from each other and adequate air exchange with grated flooring. A dedicated Stage Manager will be assigned to direct safe ingress and egress. Boxes will be disinfected after each use and cleared by compliance prior to the next team entering. There will be a small dedicated “backstage pit” zone nearby, to allow teams to make any last minute adjustments prior to their fight. Use of the Fight Viewing Boxes will not be mandatory. However, use will be encouraged as teams will be seen as the on-camera audience. Unattended boxes can be occupied by Teams not in the queue.

❖ Microphone Zones

Each team will be directed to enter the Microphone Zone, one team at a time. Teams will grab their pre-cleaned microphones (using a combination of UV and spray sanitizer) and self-attach them. An audio technician wearing PPE will supervise at a distance, and test the audio signal for final approval. Once the audio technician gives clearance, the teams will be allowed to proceed to the final isolated zone before entering the BattleBox.

❖ Pete Abrahamson/Strategy Discussion Zone

After receiving microphone approval, each team will advance one team at a time to have private fight strategy discussions with Pete Abrahamson. Pete will be located near the BattleBox entrance, and will wear PPE behind a Plexiglas barrier during all communications. After the discussions are complete, each team will be given instructions to move forward and prepare for final clearance to enter the BattleBox.

❖ Entering the BattleBox

Teams will enter the Stage Tunnel one at a time, as directed by the Stage Managers. All Stage Managers will wear ample PPE and keep a minimum of 6’ distance at all times. At this time, teams may remove their PPE, as they will now be on-camera and their entrance will be announced and recorded as they walk through the Stage Tunnel to the Box.

❖ Robot Activation

Teams will enter the box, and will activate their robots one at a time under the supervision of Trey. After successful activation, teams will move to their corresponding battle positions on the Bot Builder Stage and prepare for battle.

❖ Bot Builder Stage

A Plexiglas barrier on stage will be utilized as a safety barrier between the Red/Blue fight positions. Referees will be positioned at a distance on the outer perimeter of the box, and Referee instruction will now be relayed over speakers. Remote cameras will replace the handheld camera operators on the immediate deck, and strategically positioned to capture all the Bot Builder action on stage safely. The long-arm jib camera will also be utilized more to capture close-up coverage on the stage and during interviews.

❖ Post Fight

After completion of the fight, Bot Builders will be directed by Trey to deactivate their robots one at a time. Once deactivation is completed and approved, each team will move on to their post fight interview positions on stage. CrewBots will transport the robots for each team to separate designated exterior cool-down areas, properly distanced from one another. When batteries are cooled, teams will be able to move their batteries back to their respective charging areas for re-charging.

INTERVIEW PROCESS

We understand that as more is learned about COVID-19 and how it is spread, best practices in regards to how interviews are conducted may change. We will keep track of the latest scientific findings around the spread of COVID-19 and update the interview guidelines accordingly as this new information becomes available.

❖ Pit Interviews

Pit interviews will be conducted with at least 8 ft. distancing at all times between the Bot Builders and Pit Reporter/Camera Crew, and ideally limited to 10 minutes. Bot Builders will stay within their “U” designed pit areas, with their main workshop table between them and the Pit Reporter conducting the interview. Zoom lenses and boom mics will be utilized to maintain distancing.

❖ Post Fight Interviews

As in past seasons, Bot Builders will be interviewed on the stage after each fight. Our host will conduct the interviews from a distance through the stage speakers. Jib camera arms will help provide coverage for these interviews, allowing for close up shots of the Bot Builders, while maintaining ample distance between the camera operator and Bot Builders at all times. 19

❖ Hero Interviews

Interview areas will either be outside or in an unenclosed, “soft-wall” set, with adequate air exchange. Individual Hero Interviews will be performed from a safe distance, utilizing long lenses. The crew and producer will wear PPE at all times. After each interview, the room and equipment will be sanitized, and the set will be aired out. The microphone process for each interview will work the same as the stage entrance process, with pre-sanitized mics available for each Bot Builder to personally attach.

FOOD, SUPPLIES, BREAK AREAS & DELIVERIES

❖ Catering & Craft Service

rd Catering meals will be prepared and individually packaged by a reputable 3 party catering company, who will adhere to PPE and sanitary requirements at all times. Meals will be distributed to each team’s pit area on a pre-sanitized cart. Pit Staff will also deliver individual bins of craft service snacks to each team at the beginning of each day. All food items, beverages and utensils are required to be individually packed and sanitized before distributing.

❖ Break Areas

Tables will be made available outside in the West and East pit areas for teams to take a break or have lunch. These areas will be regularly disinfected, and tables will be adequately distanced. Tables will be available on a first come first served basis.

❖ Supply Deliveries

All supplies and delivery packages received at the front gate will be thoroughly sanitized before entering the location as a protocol. The front guard will inform a pit runner each time a package arrives. Separate receiving tables and bins will be designated for West and East pits. The pit runner will immediately inform the Casting Team once a package is delivered, and the corresponding team will be notified. Bot Builders will be allowed to make emergency runs for robot parts, food and other essential items. Entrance screening will apply always.

PPE REQUIREMENTS

Given the complexity of the new PPE workflow spaces and overall operating procedures, below is a list of areas for clarity on when PPE is a requirement or optional:

Required: Optional: - Individual Team Pits - Parking Lots (observing social distancing) - All Walkways - Outdoors (observing social distancing) - Battery Charging Tent - Outdoor Paint Zones - Internal Inspections - Outdoor Grinding Zones 20

- Functional Inspections/Test Box - BattleBox Stage - Machine Shop/Welder - Interview Areas - Pre Fight Queuing Zones - Team Pit Interviews - Microphone Zones - Photography Booth - Pete Zone - Fight Viewing Boxes - Security Gate Entrance

COMMUNICATIONS

❖ Builder Meetings

Builder meetings will now be conducted either via monitors in the pits or our dedicated Discord chat server. The casting team, Pete and Greg will be available to answer any questions via chat or while maintaining appropriate social distancing.

❖ Fight Match Monitors

Bot Builders will be able to view every fight from their respective pit area via the new monitor system. There will no longer be a lounge area where the monitors previously existed.

❖ Wifi & Internet Access

In order to provide ample Wi-Fi access to all Bot Builders for work-from-home scenarios, and online ordering of parts, the stage Wi-Fi system will be enhanced in the pits and available for each team to use. We will not allow streaming video content and music, as this will greatly impact the bandwidth and limit accessibility for all teams. This will require a collective team effort to ensure all Wi-Fi access is limited to essential needs, allowing fair access for everyone.

❖ Communications with Casting Team/Safety Team/Producing Team

We realize the importance of clear communication with the casting, safety and producing teams while in the pits. Due to the new pit layout and expanded distancing for everyone, we will implement an app-based messaging channel (i.e. Discord), which will provide Bot Builders with direct communications with all necessary teams and staff.

MINORS

❖ Minor Team Members

All minor team members must be pre-approved by Production to attend and must be an essential part of the team. Non essential minors will not be allowed to attend.

RESTROOMS

❖ Cleaning & Monitoring

There will be a significant increase to the Cleaning Crew staff, as well as new cleaning protocols implemented, based on EPA recommendations. A specialty janitorial company will facilitate all disinfecting and cleaning procedures regularly. The process will include rigorous disinfectant spray wipe downs of all restroom areas, both interior and exterior during the day (using EPA approved solutions). Each night, electrostatic disinfectant systems will be applied to every restroom stall (interior/exterior). Supplies will be closely monitored and quickly replenished as needed, and cleaning crews will be readily available to address any immediate concerns.

❖ Restrooms & Hand Washing Stations

Interior Restrooms will be separately designated for the West and East pit areas, and include a dedicated cleaning crew member for each restroom to regularly monitor supplies and clean throughout the day. We will also supplement these with a number of portable, exterior units to sufficiently serve the total number of Bot Builders. The Covid Compliance Team will have sanitizing hand wipes available, as needed. Hand sanitizers will be available at hand washing stations. Trash bins will be located directly in front of each restroom and hand washing station.

Given the unique setup of the exterior trailer toilets, we kindly remind everyone on how the flushing mechanism works: Low flush – press down on the foot pedal / High flush – lift the foot pedal up to fill the bowl with water, then press down to flush. Please remember to close toilet lids (interior/exterior) before flushing to prevent splashing exposure. In addition, there will be an increased number of hand washing stations designated for West and East pit/work areas, and will be located directly outside the pit building for easy access. The hand wash stations require pumping the foot pedals to start the water flow and continuing to pump throughout the recommended 20-second hand wash process, until fully rinsed.

INSURANCE

Although not required as a condition of my participation in the Series, I acknowledge that I, alone, am responsible for maintaining medical and other insurance policies to cover any harm I may suffer in or in connection with the Series. However, production will maintain full commercial insurance for this show, which includes general liability, auto liability, location & third party property liability and workers compensation for all employees. In addition, production has obtained an emergency health policy for all talent and Bot Builders which includes emergency accident medical coverage of up to $500,000 and sickness expenses of up to $250,000 per person.

SIGNATURE

By signing below, I hereby certify, confirm and acknowledge that (i) my participation in BattleBots Season 5 is voluntary, (ii) I have read and fully understand the Production Health & Safety Guidelines contained herein, (iii) I have been notified of, and hereby consent to, the fact that as part of my compliance with the Production Health & Safety Guidelines, I will be providing, and BattleBots Inc., Greetings Media, LLC and/or their agents will be collecting, reviewing and storing, the types of personal information, including health and biometric data, described in the these guidelines, (iv) I agree with and am willing to follow and comply with all guidelines, rules and health protocols provided to me now or in the future by BattleBots Inc., Greetings Media, LLC and their staff in order to maintain the safety and health of myself and others.

NAME: ______SIGNATURE: ______

PRINT FULL NAME: ______

FOR USE BY CUSTODIAL PARENT AND/OR LEGAL GUARDIAN OF GUEST/PERFORMER UNDER 18 YEARS OF AGE

I represent that I am the custodial parent or legal guardian of the minor named above and I affirm these Production Health & Safety Guidelines and agree that the certification, confirmation and acknowledgement contained herein binds me and said minor to all of the terms hereof. In addition, as the Custodial Parent and/or Legal Guardian, I agree that I will be directly responsible for ensuring that the minor named above follows all the guidelines, rules and health protocols describe herein which are provided now or in the future. I will indemnify, save and hold harmless BattleBots Inc., Greetings Media, LLC and their employees and affiliates from any litigation expenses, attorney fees, loss liability, damage or cost that may incur as a result of any and all claims arising out of or related to the failure to follow the Production Health & Safety Guidelines and/or the event.

NAME: ______SIGNATURE: ______

SOCIAL RESPONSIBILITY PLEDGE

Health & Safety Commitment

The current COVID-19 (Coronavirus) pandemic has created an unprecedented health crisis for our nation and planet. The impact and direct toll on humanity from the loss of life due to COVID-19, as well as the indirect impact due to economic and other factors, will be felt for years to come. As we are all living through these difficult and unpredictable times, it will require a uniformly concerted effort and commitment to personal responsibility by every person to stop the spread of coronavirus and mitigate its devastating impact.

In voluntarily participating in the BattleBots Season 5 competition in Long Beach, CA (Dates: TBD), I understand and accept that my inclusion in this event is conditional, upon agreeing to abide by a set of guidelines designated for the personal and collective health and safety of myself, and all those who are included in the event.

In light of the spread of COVID-19, I understand there are inherent risks to myself and others in participating. I have read the special mandatory health guidelines created for this event, based on CDC and Long Beach, CA guidance. I understand that these rules and pledge to abide by them at all times throughout my participation in this event, both inside the venue and including any travel to and from the event activities.

I furthermore acknowledge and accept the following rules, included in the “Production Health & Safety” handbook: § Complying with all WRI/BB-communicated guidelines § Practicing social-distancing, with my “functional group” as much as possible and always with others § Staying within my assigned “functional group” and not mixing with other groups, neither inside nor outside the venue, including while in lodging facilities and any transportation to/from the venue § Remaining outside of any event area not assigned to nor approved for my functional group § Traveling to and from the event and lodging facilities in compliance with the WRI/BB guidelines § Practicing sanitary behavior at all times, including washing my hands thoroughly throughout the day, including upon entering the facility, competition venue, before and after competition, and before departure and after returning to lodging and catering facilities/locations § Voluntarily isolating myself between event days, when I return to my lodging facilities § Immediately reporting to WRI/BB Set Medic and COVID-19 Safety Supervisor any symptoms of illness, including sore throat, cough, fever, chills, and/or shortness of breath. Further, committing to not participating and/or immediately removing myself from participation if I experience any of these symptoms. § Committing not to put myself or others in harm’s way

Any violations to the pledge, or to any of these guidelines will be addressed and discussed with the individuals, however individuals or groups of individuals that are unable and/or unwilling to adhere to safety guidelines will be removed from the premises to ensure safety for everyone else following the guidelines.

By signing this document, I confirm and acknowledge my voluntary participation in this event and agree to all rules and health protocols provided to me, in order to maintain the safety and health of others and myself.

______(Signature) (Date)

______(Print full name)

LT LT LT Z27 WELDING GAS FILL Z28 PAINT WEST EAST PAINT Z32 WEST EAST WEST RESTROOM WEST GRINDING GRINDING EAST EAST RESTROOM EXISTING UNIT

20' CLEARANCE FOR FIRE TRUCK

WEST Z34 EAST COVID BATTERY CHARGING TENT BATTERY CHARGING TENT COVID CHECK CHECK POINT POINT Z30 Z33 Z33 Z31 30" 30" TABLE TABLE x x 96" 96"

10'x10' 96" 96" x x TABLE TABLE 30" 10'x10' 30" TENT 40x110 TENT 40x110 TENT10'x10'

96" 96"

RAMP DN x x TABLE TABLE 30" 30" KEEP AREA CLEAR 12'-0" 30" 30" 12'-0" TABLE TABLE LT x x 96" 96" EAST

WEST

FOR ACCESS TO 18'x 23' 18'x 23' 18'x

TEST BOT TEST ROLL UP DOOR BOT TEST 10'x10' 30" 30" TABLE 10'x10' TABLE TENT x x VENT OUTSIDE VENT OUTSIDE VENT 10'x10' 10'x10' 96" 96" CHANGING

10'x10' 9'-0" 16'-0" TENT

CHANGING 96" 96" x x TENT TABLE TABLE TENT 30" TENT 30"

paint booth MACHINE 16'-2" 16'-2" 19'-3" empty room

INTERVIEW 22'-3" SHOP 22'-3"

2827 28 29 30 31 32 33 34 3635 3736 3837 3938 4039 4140 4241

30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE

SPACE 2 20x20TABLE 20x20 20x20 20x20 20x20 20x20 20x20 20x20 20x20 20x20 20x20 20x20 20x20 20x20 20x20

WORK METAL WORK METAL WORK METAL WORK METAL WORK METAL WORK METAL WORK METAL WORK METAL WORK METAL WORK METAL WORK METAL WORK WORK METAL WORK METAL WORK METAL TABLE METAL TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD BB PHOTOGRAPHER PAINT BOOTH WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96"

WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK 30'x10' WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK

WORK SPACE 20'x20' WORK SPACE 20'x20' WORK SPACE 20'x20' WORK SPACE 20'x20' WORK SPACE 20'x20' WORK SPACE 20'x20' WORK SPACE 20'x20' WORK SPACE 20'x20' WORK SPACE 20'x20' WORK SPACE 20'x20' WORK SPACE 20'x20' WORK SPACE 20'x20' 20'x20' SPACE WORK 20'x20' SPACE WORK 20'x20' SPACE WORK

62'-3" 20'-0" 17'-3" 22'-9" 20'-2" 20'-0" 20'-0" 62'-3" 20'-0" 20'-0" 20'-0" 20'-0" 20'-5" 20'-0" 20'-0" 76'-2" PARKING BIG ROOM PARKING POWER RUN SHEAR POWER RUN 20'-0" 17'-3" 27'-0" 19'-10" 28'-9" 20'-0" 33'-0" 46'-5" 26'-9" 19'-0" BUILDER EAST WEST

TRUCK SPACE 20'x20' SPACE WORK WORK SPACE 20'x20' 20'x20' SPACE WORK 20'x20' SPACE WORK 20'x20' SPACE WORK WORK SPACE 20'x20' WORK SPACE 20'x20' TOOLS AREA 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x2020'x20' SPACE WORK 20x2020'x20' SPACE WORK 20x2020'x20' SPACE WORK 20x2020'x20' SPACE WORK POWER WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 16x12 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD COVID TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE WORK METAL METAL WORK WORK METAL WORK METAL WORK METAL METAL WORK METAL WORK METAL WORK METAL WORK WORK METAL WORK METAL WORK METAL WORK METAL 30"x96" TABLE TABLE 30"x96" 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE

COMPLIANCE FIRE 20x2020 20x2021 20x202322 20x202423 20x202524 20x202625 20x202726 Z20 20 amp power needed 4342 4443 4544 4645 4746 4847

STORY PRODUCER STORY PRODUCER STORY PRODUCER LT 30" x 96" 30" x 96" 30" x 96" FOR WEST PITS EAST PITS PRODUCTION 181'-0"

58'-0" Z16 Z22

96" x 30" 96" x 96" x 30"

30" Z23

TABLE NPC TABLE NPC TABLE NPC

20x20 1 2 3 4 5 6 7 8 9 4948 5049 5150 51 52 53 54

TABLE 30"x96" 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE

30"x96" 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE TABLE 30"x96" 30"x96" TABLE 30"x96" TABLE TABLE 20x20 20x20

WORK WORK METAL WORK METAL WORK METAL WORK METAL WORK METAL WORK METAL

20x20 20x20 20x20 20x20 20x20 20x20 MEDIC METAL TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE WORK WORK METAL WORK METAL WORK METAL WORK METAL WORK METAL METAL WORK WORK METAL WORK METAL METAL WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE TABLE WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD 20'-0" WOOD WOOD 20'-0" WOOD WOOD 53'-2 1/4" WOOD WOOD 20'-0" WOOD WOOD 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK

30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 20'-0" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK MEDIC

15'-8" 21'-7" 10' x 10'

SPACE 20'x20' 20'x20' SPACE WORK 20'x20' SPACE WORK 20'x20' SPACE WORK 20'x20' SPACE WORK 20'x20' SPACE WORK 20'x20' SPACE WORK

WORK JAX TABLE JAX TABLE JAX TABLE

SPACE 20'x20' SPACE 20'x20' SPACE WORK 20'x20' SPACE WORK 20'x20' SPACE WORK 20'x20' SPACE WORK 20'x20' SPACE WORK WORK SPACE 20'x20' 20'x20' SPACE WORK 20'x20' SPACE WORK WORK 30" x 96" 30" x 96" 30" x 96" MEDIC TABLE OVERHEAD OBSTRUCTION @ 8' 30" x 96" 20'-0" POWER 20x20 20x20 20x20 20x20 20x20 20x20 20x20 CLEARANCE 20'-0" control box 28'-0" 23'-7" 23'-7" 19'-5" 29'-10" 24'-9" 20' POWER RUN POWER RUN 20'-0" 20'-0" 20'-0" 20'-0" 20'-2" 20'-0" 20'-0" 20'-0" 20'-0" 24'-11" 20'-0" 20'-5"

30'-0" BIG ROOM 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK SPACE 20'x20' 20x20WORK 20'x20' SPACE SPACE 20'x20' WORK WORK 20'x20' SPACE SPACE 20'x20' WORK INTERVIEW WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK WORK 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96" 30"x96"

SAFTEY TABLE SAFTEY TABLE 62'-1" SPACE 1 JAX TABLE STORY PRODUCER WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD 30" x 96" 30" x 96" WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD WOOD TABLE METAL WORK TABLE TABLE METAL WORK TABLE TABLE METAL WORK TABLE TABLE METAL WORK TABLE TABLE METAL WORK TABLE TABLE METAL WORK TABLE TABLE METAL WORK TABLE TABLE METAL WORK TABLE TABLE METAL WORK TABLE TABLE METAL WORK TABLE 30" x 96" 30" x 96" TABLE METAL WORK TABLE TABLE METAL WORK TABLE TABLE METAL WORK TABLE TABLE METAL WORK TABLE TABLE TABLE METAL WORK WORK METAL TABLE TABLE TABLE TABLE METAL WORK WORK METAL TABLE TABLE TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96" TABLE 30"x96"30"x96" TABLE TABLE 30"x96"30"x96" TABLE 56'-1"

SCALE

10 11 12 13 14 15 16 17 18 19 SAFETY 48" x 48" CASTING 55 56 57 5958 6059 2060

30" x 96" 30" x 96"

SAFTEY TABLE SAFTEY TABLE Z14 20'-0"

SCALE 48" x 48" 21'-10" LT 15'-9" 15'-9" RESTROOM RESTROOMBATHROOMS RESTROOMBATHROOMS STORAGE BATTERY Z15 RESTROOM Z17 Z18 COOL Z21 DOWN HERO BATTERY COOL Z19 DOWN

BB 2020 PITS 1 Scale: 1/32" = 1'-0"

production design art direction O-818.765.1800 C-714.768.7899 F-818.765.1808 These drawings represent visual concepts and construction suggestions only. It is not the designer's responsibility to determine structural appropriateness of this design and the designer does not assume reponsibility for improper engineering, construction, handling, or use of this scenery. By accepting these drawings, the above named production organization or producer agrees to hold harmless the designer and/or their employees from any and all legal liability claims arising from utilization of these designs.

Written dimensions on these drawings shall have precedence over scaled dimensions. Contractors shall verify, and be responsible for all dimensions and conditions on the job. The designer must be notified of any variations from the dimensions and the conditions shown by these drawings. Shop details must be submitted to the designer for approval prior to proceeding with fabrication. SURVEY ALL MEASUREMENTS ON SITE BEFORE CONSTRUCTION

DRAWING NAME BB220 Pits PROJECT Battlebots 2020 ART DIRECTOR: J.Hall, Carson Alcoser

DRAWN BY: 9-25-20 C. Alcoser SCALE: PLATE # AS NOTED 1.3

FACT SHEET FOR PATIENTS Coronavirus Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 - BGI Genomics Co. Ltd. Disease 2019 Updated: April 24, 2020 (COVID-19)

You are being given this Fact Sheet because your Why was my sample tested? sample(s) was tested for the Coronavirus Disease 2019 You were tested because your healthcare provider (COVID-19) using the Real-Time Fluorescent RT-PCR believes you may have been exposed to the virus that Kit for Detecting SARS-CoV-2. causes COVID-19 based on your signs and symptoms (e.g., fever, cough, difficulty breathing), and/or because: This Fact Sheet contains information to help you understand the risks and benefits of using this test for You live in or have recently traveled to a place the diagnosis of COVID-19. After reading this Fact where transmission of COVID-19 is known to occur, Sheet, if you have questions or would like to discuss the and/or information provided, please talk to your healthcare You have been in close contact with an individual provider. suspected of or confirmed to have COVID-19.

Testing of the samples will help find out if you may have COVID-19. For the most up to date information on COVID- 19 please visit the CDC Coronavirus Disease What are the known and potential risks and benefits of the test? 2019 (COVID-19) webpage: Potential risks include: https://www.cdc.gov/COVID19 Possible discomfort or other complications that can happen during sample collection. Possible incorrect test result (see below for more What is COVID-19? information). COVID-19 is caused by the SARS-CoV-2 virus. The

virus, which can cause mild to severe respiratory illness, Potential benefits include: was first identified in Wuhan, China, and has now spread

globally, including the United States. There is limited The results, along with other information, can help information available to characterize the spectrum of your healthcare provider make informed clinical illness associated with COVID-19 but it likely recommendations about your care. spreads to others when a person shows signs or symptoms of being sick (e.g., fever, coughing, difficulty The results of this test may help limit the spread of breathing, etc.). COVID-19 to your family and others in your community.

What is the Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2? What does it mean if I have a positive test result? The test is designed to detect the virus that causes If you have a positive test result, it is very likely that you COVID-19 in respiratory specimens, for example nasal have COVID-19. Therefore, it is also likely that you may or oral swabs. be placed in isolation to avoid spreading the virus to others. There is a very small chance that this test can

Where can I go for updates and more information? The most up-to-date information on COVID-19 is available at the CDC General webpage: https://www.cdc.gov/COVID19. In addition, please also contact your healthcare provider with any questions/concerns.

FACT SHEET FOR PATIENTS Coronavirus Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 - BGI Genomics Co. Ltd. Disease 2019 Updated: April 24, 2020 (COVID-19)

give a positive result that is wrong (a false positive justifying emergency of IVDs, unless it is terminated or result). Your healthcare provider will work with you to revoked by FDA (after which the test may no longer be determine how best to care for you based on the test used). results along with medical history, and your symptoms.

What does it mean if I have a negative test result? A negative test result means that the virus that causes COVID-19 was not found in your sample. For COVID-19, a negative test result for a sample collected while a person has symptoms usually means that COVID-19 did not cause your recent illness.

However, it is possible for this test to give a negative result that is incorrect (false negative) in some people with COVID-19. This means that you could possibly still have COVID-19 even though the test is negative. If this is the case, your healthcare provider will consider the test result together with all other aspects of your medical history (such as symptoms, possible exposures, and geographical location of places you have recently traveled) in deciding how to care for you.

It is important that you work with your healthcare provider to help you understand the next steps you should take.

Is this test FDA-approved or cleared? No. This test is not yet approved or cleared by the United States FDA. When there are no FDA-approved or cleared tests available, and other criteria are met, FDA can make tests available under an emergency access mechanism called an Emergency Use Authorization (EUA). The EUA for this test is supported by the Secretary of Health and Human Service’s (HHS’s) declaration that circumstances exist to justify the emergency use of in vitro diagnostics for the detection and/or diagnosis of the virus that causes COVID-19. This EUA will remain in effect (meaning this test can be used) for the duration of the COVID-19 declaration

FACT SHEET FOR HEALTHCARE PROVIDERS Coronavirus Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 - BGI Genomics Co. Ltd. Disease 2019 Updated: April 24, 2020 (COVID-19)

This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the This test is to be performed only using Real-Time Fluorescent RT-PCR Kit for Detecting SARS- respiratory specimens collected from individuals CoV-2. suspected of COVID-19 by their healthcare provider. The Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 is authorized for use on using respiratory specimens collected from individuals suspected of nasal washes, nasal aspirates and bronchoalveolar COVID-19 by their healthcare provider. lavage fluid (BALF). The Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 should be ordered for the All patients whose specimens are tested with this detection of COVID-19 from individuals suspected of assay will receive the Fact Sheet for Patients: Real- COVID-19 by their healthcare provider. Time Fluorescent RT-PCR Kit for Detecting SARS- The Real-Time Fluorescent RT-PCR Kit for CoV-2. Detecting SARS-CoV-2 is only authorized for use in laboratories in the United States certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high What are the symptoms of COVID-19? complexity tests. Many patients with confirmed COVID-19 have developed fever and/or symptoms of acute respiratory illness (e.g., Specimens should be collected with appropriate infection cough, difficulty breathing). However, limited information control precautions. Current guidance for COVID-19 is currently available to characterize the full spectrum of infection control precautions are available at the CDC’s clinical illness associated with COVID-19. Based on website (see links provided in “Where can I go for what is known about the virus that causes COVID-19, updates and more information” section). signs and symptoms may appear any time from 2 to 14 days after exposure to the virus. Based on preliminary Use appropriate personal protective equipment when data, the median incubation period is approximately 5 collecting and handling specimens from individuals days, but may range 2-14 days. suspected of having COVID-19 as outlined in the CDC Interim Laboratory Biosafety Guidelines for Handling and Public health officials have identified cases of COVID-19 Processing Specimens Associated with Coronavirus infection throughout the world, including the United Disease 2019 (COVID-19). For additional information, States, which may pose risks for public health. Please refer to CDC Interim Guidelines for Collecting, Handling, check the CDC webpage for the most up to date and Testing Clinical Specimens from Persons Under information. Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19) (see links provided in “Where can I go for What do I need to know about COVID-19 testing? updates and more information” section). Current information on COVID-19 for healthcare providers is available at CDC’s webpage, Information for What does it mean if the specimen tests positive for Healthcare Professionals (see links provided in “Where the virus that causes COVID-19? can I go for updates and more information” section). A positive test result for COVID-19 indicates that RNA from SARS-CoV-2 was detected, and the patient is The Real-Time Fluorescent RT-PCR Kit for infected with the virus and presumed to be contagious. Detecting SARS-CoV-2 can be used to test throat Laboratory test results should always be considered in (oropharyngeal) swabs, nasopharyngeal swabs, the context of clinical observations and epidemiological anterior nasal swabs, mid-turbinate nasal swabs, data in making a final diagnosis and patient

Report Adverse events, including problems with test performance or results, to MedWatch by submitting the online FDA Form 3500 (https://www.accessdata.fda.gov/scripts/medwatch/index.cfm?action=reporting.home) or by calling 1-800-FDA-1088

1 | Page FACT SHEET FOR HEALTHCARE PROVIDERS Coronavirus Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 - BGI Genomics Co. Ltd. Disease 2019 Updated: April 24, 2020 (COVID-19)

management decisions. Patient management should infected individuals and their household or other close follow current CDC guidelines. contacts for symptoms resulting in increased risk of spread of COVID-19 within the community, or other The Real-Time Fluorescent RT-PCR Kit for Detecting unintended adverse events. SARS-CoV-2 has been designed to minimize the likelihood of false positive test results. However, in the What is an EUA? event of a false positive result, risks to patients could The United States (U.S.) FDA has made this test include the following: a recommendation for isolation of available under an emergency access mechanism called the patient, monitoring of household or other close an Emergency Use Authorization (EUA). The EUA is contacts for symptoms, patient isolation that might limit supported by the Secretary of Health and Human contact with family or friends and may increase contact Service’s (HHS’s) declaration that circumstances exist to with other potentially COVID-19 patients, limits in the justify the emergency use of in vitro diagnostics (IVDs) ability to work, the delayed diagnosis and treatment for for the detection and/or diagnosis of the virus that the true infection causing the symptoms, unnecessary causes COVID-19. prescription of a treatment or therapy, or other unintended adverse effects. An IVD made available under an EUA has not undergone the same type of review as an FDA-approved All laboratories using this test must follow the standard or cleared IVD. FDA may issue an EUA when certain testing and reporting guidelines according to their criteria are met, which includes that there are no appropriate public health authorities. adequate, approved, available alternatives, and based on the totality of scientific evidence available, it is What does it mean if the specimen tests negative for reasonable to believe that this IVD may be effective in the virus that causes COVID-19? the detection of the virus that causes COVID-19. A negative test result for this test means that SARS- CoV-2 RNA was not present in the specimen above the The EUA for this test is in effect for the duration of the limit of detection. However, a negative result does not COVID-19 declaration justifying emergency use of IVDs, rule out COVID-19 and should not be used as the sole unless terminated or revoked (after which the test may basis for treatment or patient management decisions. A no longer be used). negative result does not exclude the possibility of COVID-19.

When diagnostic testing is negative, the possibility of a false negative result should be considered in the context of a patient’s recent exposures and the presence of clinical signs and symptoms consistent with COVID-19. The possibility of a false negative result should especially be considered if the patient’s recent exposures or clinical presentation indicate that COVID- 19 is likely, and diagnostic tests for other causes of illness (e.g., other respiratory illness) are negative. If COVID-19 is still suspected based on exposure history together with other clinical findings, re-testing should be considered by healthcare providers in consultation with public health authorities.

Risks to a patient of a false negative include: delayed or lack of supportive treatment, lack of monitoring of

2 | Page FACT SHEET FOR HEALTHCARE PROVIDERS Coronavirus Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 - BGI Genomics Co. Ltd. Disease 2019 Updated: April 24, 2020 (COVID-19)

Where can I go for updates and more information?

CDC webpages: General: https://www.cdc.gov/COVID19 Healthcare Professionals: https://www.cdc.gov/coronavirus/2019-nCoV/guidance-hcp.html Information for Laboratories: https://www.cdc.gov/coronavirus/2019- nCoV/guidance-laboratories.html Laboratory Biosafety: https://www.cdc.gov/coronavirus/2019- nCoV/lab-biosafety-guidelines.html Isolation Precautions in Healthcare Settings: https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control- recommendations.html Specimen Collection: https://www.cdc.gov/coronavirus/2019- nCoV/guidelines-clinical-specimens.html Infection Control: https://www.cdc.gov/coronavirus/2019- ncov/infection-control/index.html

FDA webpages: General: www.fda.gov/novelcoronavirus EUAs:(includes links to patient fact sheet and manufacturer’s instructions) https://www.fda.gov/medical-devices/emergency- situations-medical-devices/emergency-use-authorizations

BGI Genomics: Address: Building No. 7, BGI Park, No. 21 Hongan 3rd Street, Yantian District, Shenzhen, 518083, China

Contact number and/or email: (+86) 400-706-6615

Website:https://www.bgi.com/global/molecular-genetics/2019-ncov- detection-kit/

3 | Page

March 26, 2020

Bethany Hills, Partner Morrison & Foerster Representing: BGI Genomics Co. Ltd. 250 West 55th Street, New York, NY 10019 US

Device: Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019- nCoV Company: BGI Genomics Co. Ltd. Indication: Qualitative detection of SARS-CoV-2 nucleic acids in throat swabs and bronchoalveolar lavage fluid (BALF) from individuals suspected of COVID-19 by their healthcare provider. Emergency use of this test is limited to authorized laboratories. Authorized Laboratories: Laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 USC §263a, to perform high complexity tests. Dear Ms. Hills:

This letter is in response to your1 request that the Food and Drug Administration (FDA) issue an Emergency Use Authorization (EUA) for emergency use of your product,2 pursuant to Section 564 of the Federal Food, Drug, and Cosmetic Act (the Act) (21 U.S.C. §360bbb-3).

On February 4, 2020, pursuant to Section 564(b)(1)(C) of the Act, the Secretary of the Department of Health and Human Services (HHS) determined that there is a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad, and that involves the virus that causes COVID-19.3 Pursuant to Section 564 of the Act, and on the basis of such determination, the Secretary of HHS then declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 subject to the terms of any authorization issued under Section 564(a) of the Act.4

1 For ease of reference, this letter will use the term “you” and related terms to refer to the BGI Genomics Co. Ltd.. 2 For ease of reference, this letter will use the term “your product” to refer to the Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV used for the indication identified above. 3 On February 11, 2020, the virus tentatively named 2019-nCoV was formally designated as Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Also on February 11, 2020, the disease caused by SARS-CoV-2 was formally designated as Coronavirus Disease 2019 (COVID-19). This document uses the updated names. 4 U.S. Department of Health and Human Services, Determination of a Public Health Emergency and Declaration that Circumstances Exist Justifying Authorizations Pursuant to Section 564(b) of the Federal Food, Drug, and Page 2 – Bethany Hills (Representing) - BGI Genomics Co. Ltd.

Having concluded that the criteria for issuance of this authorization under Section 564(c) of the Act are met, I am authorizing the emergency use of your product, described in the scope Section of this letter (Section II), subject to the terms of this authorization.

I. Criteria for Issuance of Authorization

I have concluded that the emergency use of your product meets the criteria for issuance of an authorization under Section 564(c) of the Act, because I have concluded that:

1. The SARS-CoV-2 can cause a serious or life-threatening disease or condition, including severe respiratory illness, to humans infected by this virus;

2. Based on the totality of scientific evidence available to FDA, it is reasonable to believe that your product may be effective in diagnosing COVID-19, and that the known and potential benefits of your product when used for diagnosing COVID-19, outweigh the known and potential risks of your product; and

3. There is no adequate, approved, and available alternative to the emergency use of your product.5

II. Scope of Authorization

I have concluded, pursuant to Section 564(d)(1) of the Act, that the scope of this authorization is limited to the indication above.

Authorized Product Details

Your product is a qualitative test for the detection of SARS-CoV-2 nucleic acids in throat swabs and bronchoalveolar lavage fluid (BALF) from individuals suspected of COVID-19 by their healthcare provider. The SARS-CoV-2 nucleic acid is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 nucleic acid; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses.

To use your product, SARS-CoV-2 nucleic acid is first extracted, isolated and purified from human oropharyngeal swab and nasopharyngeal swab specimens, using authorized extraction methods. The purified nucleic acid is then reverse transcribed into cDNA followed by PCR amplification and detection using an authorized real-time PCR instrument. The Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV includes the following materials and control materials or other authorized materials: SARS-CoV-2 Reaction Mix, SARS-CoV-2 Enzyme Mix, SARS-CoV-2 Positive Control, SARS-CoV-2 No Template Control.

Your product requires the following control materials, or other authorized control materials, that

Cosmetic Act, 21 U.S.C. § 360bbb-3. February 4, 2020. 5 No other criteria of issuance have been prescribed by regulation under Section 564(c)(4) of the Act. Page 3 – Bethany Hills (Representing) - BGI Genomics Co. Ltd.

are to be run as outlined in the instructions for use. All controls listed below must generate expected results in order for a test to be considered valid, as outlined in the instructions for use:

Internal Control – endogeneous RNA that controls for specimen quality and demonstrates that nucleic acid was generated by the extraction process. SARS-CoV-2 Positive Control - SARS-CoV-2 RNA fragments capsulated in bacteriophage. The positive control is used to monitor for failures of rRT-PCR reagents and reaction conditions. SARS-CoV-2 No Template Control - buffer used to monitor non-specific amplification, cross-contamination during experimental setup, and nucleic acid contamination of reagents.

Your product also requires the use of additional authorized materials and authorized ancillary reagents that are not included with your product and are described in the Instructions for Use.

The above described product, when labeled consistently with the labeling authorized by FDA, entitled “Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV Instructions for Use” (available at https://www.fda.gov/medical-devices/emergency-situations-medical- devices/emergency-use-authorizations), which may be revised in consultation with, and with concurrence of, the Division of Microbiology Devices (DMD)/Office of Health Technology 7 Office of In Vitro Diagnostics and Radiological Health (OHT7-OIR)/Office of Product Evaluation and Quality (OPEQ)/Center for Devices and Radiological Health (CDRH), is authorized to be distributed to and used by authorized laboratories under this EUA, despite the fact that it does not meet certain requirements otherwise required by applicable federal law.

Your product is authorized to be accompanied by the following product-specific information pertaining to the emergency use, which is required to be made available to healthcare providers and patients:

Fact Sheet for Healthcare Providers: Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV Fact Sheet for Patients: Real-Time Fluorescent RT-PCR Kit for Detecting SARS- 2019-nCoV

I have concluded, pursuant to Section 564(d)(2) of the Act, that it is reasonable to believe that the known and potential benefits of your authorized product, when used for the qualitative detection of SARS-CoV-2 and used consistently with the Scope of Authorization of this letter (Section II), outweigh the known and potential risks of your product.

I have concluded, pursuant to Section 564(d)(3) of the Act, based on the totality of scientific evidence available to FDA, that it is reasonable to believe that your product may be effective for the indication above, when used consistently with the Scope of Authorization of this letter (Section II), pursuant to Section 564(c)(2)(A) of the Act.

FDA has reviewed the scientific information available to FDA, including the information supporting the conclusions described in Section I above, and concludes that your product (as Page 4 – Bethany Hills (Representing) - BGI Genomics Co. Ltd.

described in the Scope of Authorization of this letter (Section II)) meets the criteria set forth in Section 564(c) of the Act concerning safety and potential effectiveness.

The emergency use of your product under this EUA must be consistent with, and may not exceed, the terms of this letter, including the Scope of Authorization (Section II) and the Conditions of Authorization (Section IV). Subject to the terms of this EUA and under the circumstances set forth in the Secretary of HHS's determination under Section 564(b)(1)(C) described above and the Secretary of HHS’s corresponding declaration under Section 564(b)(1), your product is authorized for the indication above.

This EUA will cease to be effective when the HHS declaration that circumstances exist to justify the EUA is terminated under Section 564(b)(2) of the Act or when the EUA is revoked under Section 564(g) of the Act.

III. Waiver of Certain Requirements

I am waiving the following requirements for your product during the duration of this EUA:

Current good manufacturing practice requirements, including the quality system requirements under 21 CFR Part 820 with respect to the design, manufacture, packaging, labeling, storage, and distribution of your product.

IV. Conditions of Authorization

Pursuant to Section 564(e) of the Act, I am establishing the following conditions on this authorization:

BGI Genomics Co. Ltd. (You) and Authorized Distributor(s)6

A. Your product must comply with the following labeling requirements under FDA regulations: the intended use statement (21 CFR 809.10(a)(2), (b)(2)); adequate directions for use (21 U.S.C. 352(f)), (21 CFR 809.10(b)(5), (7), and (8)); any appropriate limitations on the use of the device including information required under 21 CFR 809.10(a)(4); and any available information regarding performance of the device, including requirements under 21 CFR 809.10(b)(12).

B. You and authorized distributor(s) will make your product available with the authorized labeling to authorized laboratories. You may request changes to the authorized labeling. Such requests will be made in consultation with, and require concurrence of, DMD/OHT7-OIR/OPEQ/CDRH.

C. You and authorized distributor(s) will provide to authorized laboratories the Fact Sheet for Healthcare Providers and the authorized Fact Sheet for Patients. You may request

6 “Authorized Distributor(s)” are identified by you, BGI Genomics Co. Ltd., in your EUA submission as an entity allowed to distribute your device. Page 5 – Bethany Hills (Representing) - BGI Genomics Co. Ltd.

changes to the authorized Fact Sheets. Such requests will be made in consultation with, and require concurrence of, DMD/OHT7-OIR/OPEQ/CDRH.

D. You and authorized distributor(s) will make available on your website(s) the Fact Sheet for Healthcare Providers and the Fact Sheet for Patients.

E. You and authorized distributor(s) will inform authorized laboratories and relevant public health authorities of this EUA, including the terms and conditions herein, and any updates made to your product, authorized labeling and authorized Fact Sheets.

F. Through a process of inventory control, you and authorized distributor(s) will maintain records of the authorized laboratories to which they distribute the test and number of tests they distribute.

G. You and authorized distributor(s) will collect information on the performance of your product. You will report to FDA any suspected occurrence of false positive and false negative results and significant deviations from the established performance characteristics of the product of which you become aware.

H. You and authorized distributor(s) are authorized to make available additional information relating to the emergency use of your product that is consistent with, and does not exceed, the terms of this letter of authorization.

BGI Genomics Co. Ltd. (You)

I. You will notify FDA of any authorized distributor(s) of your product, including the name, address, and phone number of any authorized distributor(s).

J. You will provide its authorized distributor(s) with a copy of this EUA and communicate to authorized distributor(s) any subsequent amendments that might be made to this EUA and its authorized accompanying materials (e.g., Fact Sheets).

K. You may request changes to the Scope of Authorization (Section II in this letter) of your product. Such requests will be made in consultation with DMD/OHT7- OIR/OPEQ/CDRH, and require concurrence of, Office of Counterterrorism and Emerging Threats (OCET)/Office of the Chief Scientist (OCS)/Office of the Commissioner (OC) and DMD/OHT7-OIR/OPEQ/CDRH.

L. You may request the addition of other instruments and associated software for use with your product. Such requests will be made in consultation with, and require concurrence of, DMD/OHT7-OIR/OPEQ/CDRH.

M. You may request the addition of other extraction methods for use with your product. Such requests will be made in consultation with, and require concurrence of, DMD/OHT7-OIR/OPEQ/CDRH.

Page 6 – Bethany Hills (Representing) - BGI Genomics Co. Ltd.

N. You may request the addition of other specimen types for use with your product. Such requests will be made in consultation with, and require concurrence of, DMD/OHT7- OIR/OPEQ/CDRH.

O. You may request the addition and/or substitution of primers or probes for use with your product. Such requests will be made in consultation with, and require concurrence of, DMD/OHT7-OIR/OPEQ/CDRH.

P. You may request the addition and/or substitution of control materials for use with your product. Such requests will be made in consultation with, and require concurrence of, DMD/OHT7-OIR/OPEQ/CDRH.

Q. You may request the addition and/or substitution of other ancillary reagents and materials for use with your product. Such requests will be made in consultation with, and require concurrence of, DMD/OHT7-OIR/OPEQ/CDRH.

R. You will evaluate the analytical limit of detection and assess traceability7 of your product with any FDA-recommended reference material(s). After submission to FDA and DMD/OHT7-OIR/CDRH’s review of and concurrence with the data, You will update its labeling to reflect the additional testing. Such labeling updates will be made in consultation with, and require concurrence of, DMD/OHT7-OIR/OPEQ/CDRH.

S. You will track adverse events, including any occurrence of false results and report to FDA under 21 CFR Part 803.

Authorized Laboratories

T. Authorized laboratories using your product will include with result reports of your product, all authorized Fact Sheets. Under exigent circumstances, other appropriate methods for disseminating these Fact Sheets may be used, which may include mass media.

U. Authorized laboratories using your product will use your product as outlined in the Instructions for Use. Deviations from the authorized procedures, including the authorized instruments, authorized extraction methods, authorized clinical specimen types, authorized control materials, authorized other ancillary reagents and authorized materials required to use your product are not permitted.

V. Authorized laboratories that receive your product will notify the relevant public health authorities of their intent to run your product prior to initiating testing.

W. Authorized laboratories using your product will have a process in place for reporting test results to healthcare providers and relevant public health authorities, as appropriate.

X. Authorized laboratories will collect information on the performance of your product and

7 Traceability refers to tracing analytical sensitivity/reactivity back to an FDA-recommended reference material. Page 7 – Bethany Hills (Representing) - BGI Genomics Co. Ltd.

report to DMD/OHT7-OIR/OPEQ/CDRH (via email: CDRH-EUA- [email protected]) and You (mailto: [email protected]) any suspected occurrence of false positive or false negative results and significant deviations from the established performance characteristics of your product of which they become aware.

Y. All laboratory personnel using your product must be appropriately trained in RT-PCR techniques and use appropriate laboratory and personal protective equipment when handling this kit, and use your product in accordance with the authorized labeling.

BGI Genomics Co. Ltd. (You), Authorized Distributors and Authorized Laboratories

Z. You, authorized distributors, and authorized laboratories using your product will ensure that any records associated with this EUA are maintained until otherwise notified by FDA. Such records will be made available to FDA for inspection upon request.

Conditions Related to Advertising and Promotion

AA. All advertising and promotional descriptive printed matter relating to the use of your product shall be consistent with the Fact Sheets and authorized labeling, as well as the terms set forth in this EUA and the applicable requirements set forth in the Act and FDA regulations.

BB. All advertising and promotional descriptive printed matter relating to the use of your product shall clearly and conspicuously state that:

This test has not been FDA cleared or approved;

This test has been authorized by FDA under an EUA for use by authorized laboratories;

This test has been authorized only for the detection of nucleic acid from SARS- CoV-2, not for any other viruses or pathogens; and

This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

No advertising or promotional descriptive printed matter relating to the use of your product may represent or suggest that this test is safe or effective for the detection of SARS-CoV-2.

The emergency use of your product as described in this letter of authorization must comply with the conditions and all other terms of this authorization.

Page 8 – Bethany Hills (Representing) - BGI Genomics Co. Ltd.

V. Duration of Authorization

This EUA will be effective until the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 is terminated under Section 564(b)(2) of the Act or the EUA is revoked under Section 564(g) of the Act.

Sincerely,

______RADM Denise M. Hinton Chief Scientist Food and Drug Administration

Enclosures From your phone go to: https://bb.backtoset.app

Once there use your email to create an account. You will be sent a PIN for verification.

Make sure to add the app to to your phone as shown.

You will need to sign in everyday before coming to set. When you Check in, open the app to show Me your “Cleared to Work”. PROJECT NAME

BATTLEBOTS

PROJECT ADRRESS 2401 EAST WARLOW ROAD. LONG BEACH, CA. 90807 CLIENT

MIKE MAGANA

MECHANICHAL ENGINEER

JOB NUMBER COMPLETION DATE

20-58 Wednesday, September 16, 2020

TABB TECHNICIAN TABB SUPERVISOR

BJR, BTR BRUCE J. REYNOLDS

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] «

Bruce J Reynolds Has successfully completed the requirements for TABB Supervisor

TB1098947S March 27, 2019

Renewed: March 27, 2019

March 31, 2021

Company:

Certification: TABB Supervisor

Certification Code: TB1098947S

Expiration Date: March 31, 2021

Print Date: 04/04/2019

Bruce Reynolds

TABB Supervisor TB1098947S March 31, 2021

Printed: 04/04/2019 Bruce J Reynolds Has successfully completed the requirements for TABB Technician

BB1098947T March 26, 2019

Renewed: March 26, 2019

March 31, 2021

Certification: TABB Technician

Certification Code: BB1098947T

Expiration Date: March 31, 2021

Print Date: 04/04/2019

Bruce Reynolds

TABB Technician BB1098947T March 31, 2021

Printed: 04/04/2019 Bruce J Reynolds Has successfully completed the requirements for Fire and Smoke Damper Technician

FLS11098947T March 26, 2019

Renewed: March 26, 2019

March 31, 2021

SYMBOL & DEFINITIONS SHEET

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « SYMBOL & DEFINITIONS SHEET

------Absolute Value: The numerical value without regard to its sign. For example, the absolute value of 3 is 3, and the absolute value of -3 is also 3.

Acceleration: The vector quantity that specifies the time rate of change of velocity.

Accuracy: The capability of an instrument to indicate the true value of a measured quantity.

Adjusting: The varying of system flows by partially closing balancing devices, such as dampers and valves, and varying fan speeds to achieve optimum system operating conditions within design and installation limitations.

AHJ: Authority Having Jurisdiction is the local governing authority having jurisdiction over a designated portion of the project.

Air Change Rate (also referred to as Air Changes per Hour or ACH): The number of times the total air volume of a defined space is replaced in a given unit of time. Ordinarily computed by dividing the total volume of the subject space into the total volume of air supplied to or exhausted from the space per unit of time. (Supply air volume is used to calculate ACH in rooms requiring a positive pressure. Exhaust air volume is used to calculate ACH in rooms requiring a negative pressure.)

Air Exchange Rate: Air exchange rate is the rate at which outdoor air replaces indoor air within a given space or room.

AHU: Air Handling Unit

Balancing: The methodical proportioning of air and hydronic flows through the system mains, branches, and terminal devices using acceptable procedures to achieve the specified airflow or hydronic flow within installation, testing and design limitations.

Calibrate (Calibration): The act of comparing an instrument of unknown accuracy with a standard of known accuracy to detect, correlate, report, or correct by adjustment unacceptable variation in the accuracy of the tested instrument.

Conformed Contract Documents: Current and complete documents.

Corrective Action: Repairing, replacing, re-building, calibrating or adjusting of equipment or systems.

Deficiency: Any installation, measurement, or finding outside the tolerances allowed by project specifications.

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « SYMBOL & DEFINITIONS SHEET

IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII Differential Pressure (ΔP): The difference between two pressures measured with respect to the same reference pressure.-- Differential Pressure (ΔP): The difference between two pressures measured with respect to the same reference pressure.

Diffuser: Outlet designed to mix supply air and room air, and to distribute it in varying directions (may or may not have an integral damper).

Diversity: In air or hydronic systems, diversity is the term used to describe the difference in air or water volume between the prime mover (fan or pump) and the terminal elements. An example would be a fan system where the fan is sized for 85% of the total air flow at the terminals. In this example, the diversity would be represented as 85% diversity.

DX: Direct Expansion refrigerant type system.

Embedded Motor: Any motor that is inaccessible without disassembling the equipment it is mounted in. (Examples: cassette ductless units, Fan Powered VAV, VRF fan coil units, direct drive ceiling exhaust fans, etc.)

EOR: Engineer Of Record. The engineer responsible for project plans and specifications.

Environmental Systems: Systems using a combination of mechanical equipment, airflow, water flow and electrical energy to provide heating, ventilating, air conditioning, humidification, and dehumidification for the purpose of human comfort or process control of temperature and humidity.

Equal Area Method: Term used to describe the more common method of duct traversing by averaging velocity readings taken from the center of equal areas of the duct cross-section.

ESP: External Static Pressure.

Face Velocity: The average velocity of air moving perpendicular to the hood face, usually expressed in feet per minute (fpm) or meters per second (m/s).

Fenestration: Any opening in a building structure such as windows, skylights, window walls, doors, louvers, and access panels.

Function: The particular type of data measurement for Instrumentation and Calibration.

GRD: An acronym referring to Grilles, Register and Diffusers (see individual definitions).

Grille: Louvered or perforated face over an opening with no balancing damper integral to the device.

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « SYMBOL & DEFINITIONS SHEET

High Efficiency Particulate Air Filter (HEPA): An extended media, dry-type filter in a rigid frame having a minimum particle-collection efficiency of 99.97 percent for 0.3 micron particulate at a rated airflow.

IP: Inch/Pound Term used to describe measurement system used in the United States and elsewhere.

Log Tchebycheff Method or Log-T: An alternate approved method of laying out a duct traverse as opposed to the Equal Area Method.

Memory Stop: An adjustable mechanical device that allows a valve to be closed (for service) and limits the valve to a predetermined position when re-opened.

Micron: A unit of measurement equal to one-millionth of a meter or approximately 0.00003937 inch. (25 microns are approximately 0.001 inch).

Certified TAB Report: The data presented in a Certified TAB Report accurately represents system measurements obtained in accordance with the current Procedural Standard for Testing, Adjusting, and Balancing of Environmental Systems. A Certified TAB Report does not necessarily guarantee that systems included are balanced to design flows. Any variances from design quantities, which exceed specific tolerances or contract document tolerances, are noted in the test-adjust-balance report project summary.

Certified Professional (CP): An individual who has successfully passed the professional level certification examinations and maintains the CP re-certification requirements.

Procedural Standard for Testing, Adjusting and Balancing of Environmental Systems (Procedural Standard): A publication that outlines responsibilities, instrument standards, report requirements, measurement procedures and job performance expectations for the CF, CP and CT.

NPSH: Net Positive Suction Head.

OA: Outside Air.

Phase: To schedule or order activities so as to be available or complete when, or as, needed.

Point-to-Point Verification: This activity confirms a specific sensor or device is paired and connected to the proper controller.

Potable Water: Water that is satisfactory for drinking, culinary and domestic purposes and that meets the requirements of the Health Authority Having Jurisdiction.

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « SYMBOL & DEFINITIONS SHEET

Precision: The ability of an instrument to produce repeatable readings of the same quantity under the same conditions. The precision of an instrument refers to its ability to produce a tightly grouped set of values around the mean value of the measured quantity.

Procedure: A defined approach that outlines the execution of a sequence of work or operations. Procedures are used to produce repeatable and defined results.

QAP: Quality Assurance Program.

RA: Return Air. Sometimes used to designate Relief Air.

Range: The upper and lower limits of an instrument’s ability to measure values for which the instrument is calibrated.

Recommended: Testing procedures, measurements, and/or data gathering, whether included in the cer-

tified report or otherwise, that enables further diagnostic review and troubleshooting above and beyond the requirements for report certification.

Register: Combination grille and damper assembly. Resolution: The smallest change in a measured variable that an instrument can detect; the implementation of actions that correct a tested or observed deficiency.

Required: Designates any data, function or action that must be gathered or performed to qualify as a certified report, unless such data is impossible to gather or a given function or action cannot be performed. Any information or action that cannot be fulfilled in accordance with this Procedural Standard must be clearly explained in the final report summary.

RPM: Revolutions Per Minute. RTU: Roof Top Unit.

SA: Supply Air.Shaft Pressurization System: A type of smoke-control system intended to positively pressurize stair and elevator shafts with outdoor air by using fans to keep smoke from contaminating the shafts during an alarm condition.

Shutoff Head: Term used to describe the dynamic measurement of a pump’s total dynamic head at no flow. Performed by closing the pump discharge valve only.

SI: International System of Units (Système international d’unités), the modern international standard version of the metric system.

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « SYMBOL & DEFINITIONS SHEET

Smoke-Control System: An engineered system that uses fans to produce airflow and pressure differences across barriers to limit smoke movement. 4

Smoke-Control Zone: A space within a building that is enclosed by smoke barriers and is a part of a zoned smoke-control system.

Stairwell Pressurization System: A type of smoke-control system that is intended to positively pressurize stair towers with outdoor air by using fans to keep smoke from contaminating the stair towers during an alarm condition.

Static Head: The pressure due to weight of fluid above the point of measurement. In a closed system, static head is equal on both sides of the pump.

Static Pressure (SP): In an HVAC System, the potential energy a system possesses at the point of measurement to produce and maintain fluid flow against system resistance. Can be positive or negative relative to the appropriate reference pressure.

Static Test: Test or inspection that validates a specified static condition such as pressure testing. Static tests may be specification or code initiated.

Suction Head: The height of fluid surface above or below the centerline of a pump on the suction side.

System Effect: A phenomenon that can create undesired or unpredicted conditions that cause reduced capacities in all or part of a system. System Effect cannot be measured directly, but can be estimated.

TDH: Total Dynamic Head. The total equivalent height that a fluid is to be pumped, taking into account friction losses in the pipe.

Terminal Device: A point where the controlled medium enters or leaves the distribution system (air side; grille, register or diffuser) (hydronic side; heat transfer elements such as coils, radiant panels, chill beams, etc.).

Terminal Unit: A device that regulates the amount and/or the temperature of the controlled medium.

Test Procedure: A written protocol that defines methods, personnel, and expectations for tests conducted on components, equipment, assemblies, systems, and interfaces among systems.

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « SYMBOL & DEFINITIONS SHEET

Testing: The use of specialized and calibrated instruments to measure parameters such as temperature, pressure, vapor flow, airflow, fluid flow, fluid quantities, rotational speed, electrical characteristics, velocity, sound and vibration level, air and hydronic quantities, and other data in order to determine performance, operation, or function.

Testing, Adjusting and Balancing (TAB): A systematic process or service applied to HVAC systems, and other environmental systems, to achieve and document air and hydronic flow rates.

Total Pressure (TP): The sum of static pressure and velocity pressure at the point of measurement in the system (TP = SP + VP). Value may be positive or negative.

TSP: Total Static Pressure.

Troubleshooting: Procedural activities for investigating a specific fault or failure of a system or piece of equipment.

VAV: Variable Air Volume.

Velocity: The vector quantity that specifies the time rate of change of displacement.

Velocity Pressure (VP): The kinetic energy of flow exerted only in the direction of flow. Velocity pressure cannot be measured directly. It is the difference between total pressure and static pressure at the point of measurement.

Zone: A volume of building served by a single ventilation system. For buildings with natural ventilation only, the whole building is considered a zone.

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « TABB REPORT SUMMARY SHEET

1 HANGER NORTH HAS 2.4 ACH OF OSA CIRCULATION. 2 HANGER SOUTH HAS 2.8 ACH OF OSA CIRCULATION. 3 OSA = OUTSIDE AIR 4 ACH = AIR CHANGES PER HOUR. 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « SUPPLY FAN OUTLET SHEET

UNIT. ROOM OUTLET AK DESIGN ACTUAL SIZE TYPE NOTES # # # FACTOR CFM FPM CFM FPM

HV-1 OSA NORTH 1 68" X 102" 48.17 SO NS 29287 608 TOTAL NS 29287

HV-2 OSA NORTH 1 68" X 102" 48.17 SO NS 30203 627 TOTAL NS 30203

HV-3 OSA NORTH 1 68" X 102" 48.17 SO NS 24181 502 TOTAL NS 24181

HV-4 OSA NORTH 1 68" X 102" 48.17 SO NS 26783 556 TOTAL NS 26783

HV-5 OSA NORTH 1 68" X 102" 48.17 SO NS 27842 578 TOTAL NS 27842

HV-6 OSA NORTH 1 68" X 102" 48.17 SO NS 29576 614 TOTAL NS 29576

HV-7 OSA NORTH 1 68" X 102" 48.17 SO NS 29480 612 TOTAL NS 29480

NOTES:

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « SUPPLY FAN OUTLET SHEET

UNIT. ROOM OUTLET AK DESIGN ACTUAL SIZE TYPE NOTES # # # FACTOR CFM FPM CFM FPM

HV-8 OSA NORTH 1 68" X 102" 48.17 SO NS 26108 542 TOTAL NS 26108

HV-9 OSA NORTH 1 68" X 102" 48.17 SO NS 24759 514 TOTAL NS 24759

HV-10 OSA SOUTH 1 68" X 102" 48.17 SO NS 23989 498 TOTAL NS 23989

HV-11 OSA SOUTH 1 68" X 102" 48.17 SO NS 29480 612 TOTAL NS 29480

HV-12 OSA SOUTH 1 68" X 102" 48.17 SO NS 28806 598 TOTAL NS 28806

HV-13 OSA SOUTH 1 68" X 102" 48.17 SO NS 27312 567 TOTAL NS 27312

HV-14 OSA SOUTH 1 68" X 102" 48.17 SO NS 28998 602 TOTAL NS 28998

NOTES:

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « SUPPLY FAN OUTLET SHEET

UNIT. ROOM OUTLET AK DESIGN ACTUAL SIZE TYPE NOTES # # # FACTOR CFM FPM CFM FPM

HV-15 OSA SOUTH 1 68" X 102" 48.17 SO NS 30877 641 TOTAL NS 30877

HV-16 OSA SOUTH 1 68" X 102" 48.17 SO NS 26060 541 TOTAL NS 26060

HV-17 OSA SOUTH 1 68" X 102" 48.17 SO NS 23989 498 TOTAL NS 23989

HV-18 OSA SOUTH 1 68" X 102" 48.17 SO NS 24663 512 TOTAL NS 24663

HV-19 OSA SOUTH 1 68" X 102" 48.17 SO NS 26638 553 TOTAL NS 26638

HV-20 OSA SOUTH 1 68" X 102" 48.17 SO NS 27120 563 TOTAL NS 27120

HV-21 OSA SOUTH 1 68" X 102" 48.17 SO NS 30925 642 TOTAL NS 30925

NOTES:

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « EXHAUST FAN OUTLET SHEET

UNIT. ROOM OUTLET AK DESIGN ACTUAL SIZE TYPE NOTES # # # FACTOR CFM FPM CFM FPM

EF-1 EA SOUTH 1 48" RD 12.56 DO NS NS 6431 512 TOTAL NS 6431

EF-2 EA SOUTH 1 48" RD 12.56 DO NS NS 6581 524 TOTAL NS 6581

EF-3 EA SOUTH 1 48" RD 12.56 DO NS NS 6506 518 TOTAL NS 6506

EF-4 EA SOUTH 1 48" RD 12.56 DO NS NS 6607 526 TOTAL NS 6607

EF-5 EA SOUTH 1 48" RD 12.56 DO NS NS 0 0 TOTAL NS 0 1.

EF-6 EA NORTH 1 48" RD 12.56 DO NS NS 6481 516 TOTAL NS 6481

EF-7 EA NORTH 1 48" RD 12.56 DO NS NS 6858 546 TOTAL NS 6858

NOTES: 1. EF-5 REMOVED FROM ROOF. NOT OPPERATIONAL AT TIME OF AIR FLOW SURVEY.

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « EXHAUST FAN OUTLET SHEET

UNIT. ROOM OUTLET AK DESIGN ACTUAL SIZE TYPE NOTES # # # FACTOR CFM FPM CFM FPM

EF-8 EA SOUTH 1 48" RD 12.56 DO NS NS 6431 512 TOTAL NS 6431

NOTES:

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « OSA AIR CHANGES PER HOUR SHEET

POSSITIVE ROOM SHEET PRESS. OSA ACH OSA TOTAL EA TOTAL CFM ROOM # DESC. CU. FT. ACTUAL DESIGN ACTUAL DESIGN ACTUAL DESIGN ACTUAL POSS. NEG.

HANGER NORTH 6114640 P NS 2.4 22929.9 248219 NS 19770 228449 NA HANGER SOUTH 7015000 P NS 2.8 26306.25 328857 NS 26125 302732 NA

NOTES: 1. OSA DESIGN WAS FIGURED OFF CA TITLE 24 TABLE 120.1-A ( MINIMUM VENTILATON RATE OF 0.15 CFM PER SQFT.)

« Freedom Air Balance Inc. « P.O. Box 720425 | Piñon Hills, CA 92372 « « 760.885.8898 « [email protected] « STATE OF CALIF ORNIA OUTDOOR AIR ACCEPTANCE C E C - N R C A- M C H-02- A (Revis ed 07/16) CALIFORNIA ENERGY CO M MISSION CERTIFICATE OF ACCEPTA NCE NRCA-MCH -02-A Outdoor Air Acceptance (Page 1 of 3) Project Na me: E nf orc e m e nt A g e nc y: Per mit Nu mber: BATTLEBOTS CI T Y NA Project Address: Cit y: Zi p C o d e: 2401 EAST WARLO W ROAD L O N G B E A C H 9 0 8 0 7

Syste m Na me or Identification/Tag: Syste m Location or Area Served: H V-1 - H V-9 NORTH HANGER

Note: Sub mit one Certificate of Acceptance for each syste m Enforce ment Agency Use: Checked by/ Date that must de monstrate co mpliance.

Verify measured outside airflo w reading is within 10 % of the total required outside airflo w. Required for all newly installed H V AC I nt e nt: units. Reference MC H -03 (Colu mn 14) or Mechanical Equip ment Schedules.

A. Construction Inspection Note : M C H-02-A can be perfor med in conjunction with M C H-07-A Supply Fan VF D Acceptance (if applicable) since testing activities overlap.

1. Supporting docu mentation needed to perfor m test includes: As-built and/or design docu ments (for exa mple, Mechanical Equip ment Schedules, Equip ment a. Start-Up Sheets or Balancing Reports). b. 2016 Building Energy Efficiency Standards Nonresidential Co mpliance Manual ( N A7.5.1.1 Ventilation Syste ms: Variable Air Syste ms At -A-Glance and NA7.5.1.2 Constant Volu me Syste ms Outdoor Air Acceptance At -A-Glance). c. 2016 Building Energy Efficiency Standards. 2. Instru mentation needed to perfor m test includes: a. W atc h b. Calibrated means to measure airflo w (i.e. hot-wire ane mo meter , velocity pressure probe, etc.). i. M ethod and equip ment used:______A D M 8 8 0 C ii. Equip ment calibration date ( must be within one year):______1 2/ 2 0 1 9 3. Syste m type (check either VAV or CAV): ✔ VAV ✔ CAV a. Check if Variable Air Volu me (VAV) and co mplete the follo wing: i. Outside airflo w is either factory calibrated or field calibrated. ✔ Check if factory calibrated and attach calibration certification. ✔ Check if field calibrated and attach calibration results. ii. Da mper Control ( must be checked): ✔ D y n a mic d a m p er c o ntr ol is b ei n g us e d t o c o ntr ol o utsi d e air. ( T his is N O T a fix e d mi ni m u m p ositi o n). iii. One of the follo wing dyna mic controls is being utilized to control outside air (check method used ) ✔ Outdoor Air CF M Co mpensation ✔ Energy Balance Method ✔ De mand Control Ventilation ✔ Return Fan Tracking ✔ Injection Fan Method ✔ Dedicated Mini mu m Ventilation Da mper with Pressure Control ✔ Other Active Control, Describe: ______b. Check if Constant Air Volu me (C AV) and verify the follo wing: ✔ Syste m is designed to provide a fixed mini mu m OSA when the unit is on. 4. Method of delivering outside air to the unit (c heck one of the follo wing): ✔ O utsi d e air is d uct e d t o th e r et ur n air ple n u m. C o nfir m th at outsi d e air is d uct e d t o wit hi n (c h ec k on e of th e f oll o wi n g): ✔ 5 f t. of th e u nit. ✔ 1 5 ft. of th e u nit, wit h t h e air dir ect e d s u bst a nti all y to w ar d t h e u nit. ✔ R et ur n air pl e n u m is NO T use d t o distri b ut e o utsi d e air to th e u nit. (i. e. outsi d e air is duct e d dir ectl y to th e u nit , o uts i d e air is provided independent of the unit, or econo mizer) 5. Pre-occupancy purge has been progra m med for the 1-hour period i m mediately before the building is nor mally occupied to provide (one of the follo wing methods must be verified and checked): ✔ The conditioned floor area ti mes the ventilation rate fro m the 2016 Building Energy Efficiency Standards T ABLE 120.1- A, or 15 cf m per person ti mes the expected nu mber of occupants, whichever is greater. ✔ Co mplete air changes to the zone served by the air handler.

C A Building Energy Efficiency Standards - 2016 Nonresidential Co mpliance J ul y 2 0 16 STATE OF CALIF ORNIA OUTDOOR AIR ACCEPTANCE C E C - N R C A- M C H-02- A (Revis ed 07/16) CALIFORNIA ENERGY CO M MISSION CERTIFICATE OF ACCEPTA NCE NRCA-MCH -02-A Outdoor Air Acceptance (Page 2 of 3) Project Na me: E nf orc e m e nt A g e nc y: Per mit Nu mber: BATTLEBOTS CI T Y NA Project Address: Cit y: Zi p C o d e: 2401 EAST WARLO W ROAD L O N G B E A C H 9 0 8 0 7

Syste m Na me or Identification/Tag: Syste m Location or Area Served: H V-1 - H V-9 NORTH HANGER

B. N A7.5.1.1 Outdoor Air Acceptance Functional Testing C A V VAV Step 1: Disable de mand control ventilation (if applicable) ✔ ✔ Step 2: Verify unit is not in econo mizer mode during test (econo mizer disabled) ✔ ✔ Note: Shaded boxes do not apply for C AV syste ms Step 3: C A V and V A V testing at full supply airflo w A dj ust su p pl y air to ac hi e v e desi g n airfl o w or maxi m u m airfl o w at full a. cooling. Record VF D speed ( Hz). Hz b. Measured outdoor airflo w reading (cf m) 2 4 8 2 1 9 cf m cf m Required outdoor airflo w (cf m) (fro m MC H-03, Colu mn 14, or c. 2 2 9 2 9. 9 Mechanical Equip ment Schedules). cf m cf m Ti m e f or o utsi d e air d a m p er t o st a biliz e aft er f ull s u p pl y airfl o w is ac hi e v e d d. ( mi n ut es): mi n Step 4: V A V testing at reduced supply airflo w C A V V A V a. A dj ust s u p pl y airfl o w t o eit h er t h e s u m of t h e mi ni m u m z o n e airfl o ws, f ull h e ati n g, or 3 0 % of t h e total design airflo w. Record VF D speed ( Hz). Hz b. M easured outdoor airflo w reading (cf m). cf m c. Required outdoor airflo w (cf m) (fro m MC H-03, Colu mn 14, or M echanical Equip ment Schedules). cf m d. Ti me for outside air da mper to stabilize after reduced supply airflo w is achieved ( minutes): mi n Step 5: Retur n to initial con diti o ns (check) ✔ ✔

C. Testing Calculations & Results

Deter mine Percent Outside Air at full supply airflo w (% O A FA ) for Ste p 3.

a. %OA FA = Measured outdoor airflo w reading /Required outdoor airflo w. (Step3b/Step3c) 1 0. 8 3 % %

b. %OA FA is wit hi n 1 0 % of d esi g n O utsid e Air. (9 0 % ≤ %O A FA ≤ 1 1 0 %) Y es N o Y es N o c. Outside air damper position stabilizes within 5 minutes. (Step 3d < 5 minutes) Y es N o

Deter mine Percent Outside Air at reduced supply airflo w (% O A RA ) for St e p 4. (V A V o nl y)

a. %OA RA = Measured outdoor airflo w reading /Required outdoor airflo w reading. (Step4b/Step4c) %

b. %OA RA is wit hi n 1 0 % of d esi g n O utsid e Air. (9 0 % ≤ % O A RA ≤ 1 1 0 %) Y es N o c. O utsi d e air d am p er p ositi o n st a biliz es wit hi n 5 mi n ut es. (St e p 4 d < 5 mi n ut es) Y es N o Note: The intent of this test is to ensure that 1) all air handlers provide the mini mu m a mount of OS A and 2) V A V air handlers use d yna mic controls to avoid over ventilation.

D . E v al u ati o n

✔ P ASS: All Construction Inspection responses are co mplete and Testing Calculations & Results responses are positive.

OSA SET T O 10.83 % HI G H D UE T O C OVID 19.

C A Building Energy Efficiency Standards - 2016 Nonresidential Co mpliance J ul y 2 0 16 STATE OF CALIF ORNIA OUTDOOR AIR ACCEPTANCE C E C - N R C A- M C H-02- A (Revis ed 07/16) CALIFORNIA ENERGY CO M MISSION CERTIFICATE OF ACCEPTA NCE NRCA-MCH -02-A Outdoor Air Acceptance (Page 3 of 3) Project Na me: E nf orc e m e nt A g e nc y: Per mit Nu mber: BATTLEBOTS CI T Y NA Project Address: Cit y: Zi p C o d e: 2401 EAST WARLO W ROAD L O N G B E A C H 9 0 8 0 7

Syste m Na me or Identification/Tag: Syste m Location or Area Served: H V-1 - H V-9 NORTH HANGER

DOCU MENTATION AUTHOR'S DECLARATION STATEMENT 1. I certify that this Certificate of Acceptance docu mentation is accurate and co mplete. Docu mentation Author Na me: BRUCE J REY N OLDS Docu mentation Author Signature: Docu mentation Author Co mpany Na me : FREED O M AIR BALA NCE, I NC. Date Signed: A d dr ess: P O B OX 720425 A T T C ertific ati o n I d e ntific ati o n (If a p plic a bl e): BB1098947T MT City/State/Zip: PI N O N HILL S, C A. 9 2 3 7 2 P h o n e: 760-885-8898 FIELD TECHNICIAN'S DECLARATI O N STATE ME NT I certify the follo wing u nder pe nalty of perjury, un der t he la ws of t he State of California: 1. The infor mation provided on this Certificate of Acceptance is true and correct. 2. I a m the person who perfor med the acceptance verification reported on this Certificate of Acceptance (Field Technician). 3. The construction or installation identified on this Certificate of Acceptance co mplies with the applicable acceptance require ments indicated in the plans and specifications approved by the enforce ment agency, and confor ms to the applicable acceptance require ments and procedures specified in Reference Nonresidential Appendix NA7. 4. I have confir med that the Certificate(s) of Installation for the construction or installation identified o n this Certificate of Acceptance has been co mpleted and signed by the responsible builder/installer and has been posted or made available with the building per mit(s) issued for the building. Field Technician Na me: BRUCE J REY N OLDS Field Technician Signature:

Field Technician Co mpany Na me: FREED O M AIR BALA NCE, I NC. P ositi o n wit h C o m p a n y ( Titl e): OWNER A d dr ess: A T T C ertific ati o n I d e ntific ati o n (if a p plic a bl e) : P O B OX 720425 BB1098947T MT City/State/Zip: PI N O N HILL S, C A. 9 2 3 7 2 P h o n e: 760-885-8898 Date Signed: RESP ONSIBLE PERS ON'S DECLARATI ON STATE MENT I certify the follo wing u nder pe nalty of perjury, un der t he la ws of t he State of California: 1. I a m the Field Technician, or the Field Technician is acting on my behalf as my e mployee or my agent and I have revie wed the infor mation provided on this Certificate of Acceptance. 2. I a m eligible under Division 3 of the Business and Professions Code in the applicable classification to accept responsibility for the syste m design, construction or installation of features, materials, co mponents, or manufactured devices for the scope of work identified on this Certificate of Acceptance and attest to the declarations in this state ment (responsible acceptance person). 3. The infor mation provided on this Certificate of Acceptance substantiates that the construction or installation identified on this Certificate of Acceptance co mplies with the acceptance require ments indicated in the plans and specifications approved by the enforce ment agency, and confor ms to the applicable acceptance require ments and procedures specified in Reference Nonresidential Appendix NA7. 4. I have confir med that the Certificate(s) of Installation for the construction or installation identified o n this Certificate of Accepta nce has been co mpleted and is posted or made available with the building per mit(s) issued for the building. 5. I will ensure that a co mpleted, signed copy of this Certificate of Acceptance shall be posted, or made available with the building per mit(s) issued for the building, and made available to the enforce ment agency for all applicable inspections. I understand that a signed copy of this Certificate of Acceptance is required to be included with the docu mentation the builder provides to the building o wner at occupancy. Responsible Acceptance Person Na me: BRUCE J REY N OLDS Responsible Acceptance Person Signature: Responsible Acceptance Person Co mpany Na me: P ositi o n wit h C o m p a n y ( Titl e): FREED O M AIR BALA NCE, I NC. OWNER A d dr ess: P O B OX 720425 CSLB License: 1 0 5 4 6 6 0 City/State/Zip: PI N O N HILL S, C A. 9 2 3 7 2 P h o n e:760-885-8898 Date Signed:

C A Building Energy Efficiency Standards - 2016 Nonresidential Co mpliance J ul y 2 0 1 6

What you should know about COVID-19 to protect yourself and others

Know about COVID-19 milk Practice social distancing • Coronavirus (COVID-19) is an illness caused • Buy groceries and medicine, by a virus that can spread from person go to the doctor, and to person. complete banking activities • The virus that causes COVID-19 is a new online when possible. coronavirus that has spread throughout • If you must go in person, the world. stay at least 6 feet away from • COVID-19 symptoms can range from mild others and disinfect items you (or no symptoms) to severe illness. must touch. • Get deliveries and takeout, and limit in-person contact as Know how COVID-19 is spread much as possible. • You can become infected by coming into close contact (about 6 feet or two Prevent the spread of arm lengths) with a person who has COVID-19. COVID-19 is primarily spread COVID-19 if you are sick from person to person. • Stay home if you are sick, • You can become infected from respiratory except to get medical care. droplets when an infected person coughs, • Avoid public transportation, sneezes, or talks. ride-sharing, or taxis. • You may also be able to get it by touching a • Separate yourself from other surface or object that has the virus on it, and people and pets in your home. then by touching your mouth, nose, or eyes. • There is no specific treatment for COVID-19, but you can seek Protect yourself and others from COVID-19 medical care to help relieve your symptoms. • There is currently no vaccine to protect against COVID-19. The best way to protect • If you need medical attention, yourself is to avoid being exposed to the call ahead. virus that causes COVID-19. • Stay home as much as possible and avoid Know your risk for close contact with others. severe illness • Wear a cloth face covering that covers your nose and mouth in public settings. • Everyone is at risk of getting COVID-19. • Clean and disinfect frequently touched surfaces. • Older adults and people of any age who have serious • Wash your hands often with soap and water underlying medical conditions for at least 20 seconds, or use an alcohol- may be at higher risk for more based hand sanitizer that contains at least severe illness. 60% alcohol.

cdc.gov/coronavirus

CS 314937A 04/15/2020 How to Safely Wear and Take Off a Cloth Face Covering Accessible: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/diy-cloth-face-coverings.html

WEAR YOUR FACE COVERING CORRECTLY • Wash your hands before putting on your face covering • Put it over your nose and mouth and secure it under your chin • Try to fit it snugly against the sides of your face • Make sure you can breathe easily • Do not place a mask on a child younger than 2

USE THE FACE COVERING TO PROTECT OTHERS • Wear a face covering to protect others in case you’re infected but don’t have symptoms • Keep the covering on your face the entire time you’re in public R E I R • Don’t put the covering around your neck or up on your forehead R A B H T • Don’t touch the face covering, and, if you do, clean your hands O L C

FOLLOW EVERYDAY HEALTH HABITS PHARMACY • Stay at least 6 feet away from others • Avoid contact with people who are sick • Wash your hands often, with soap and water, for at least 20 seconds each time • Use hand sanitizer if soap and water are not available

TAKE OFF YOUR CLOTH FACE COVERING CAREFULLY, WHEN YOU’RE HOME • Untie the strings behind your head or stretch the ear loops • Handle only by the ear loops or ties • Fold outside corners together • Place covering in the washing machine • Wash your hands with soap and water

Cloth face coverings are not surgical masks or N-95 respirators, both of which should be saved for health care workers and other medical first responders.

For instructions on making a cloth face covering, see: cdc.gov/coronavirus

CS 316439A 05/18/2020 Important Information About Your Cloth Face Coverings Print Resources Web Page: https://www.cdc.gov/coronavirus/2019-ncov/communication/print-resources.html

As COVID-19 continues to spread within the United States, CDC has recommended additional measures to prevent the spread of SARS-CoV-2, the virus that causes COVID-19. In the context of community transmission, CDC recommends that you:

Practice social Stay at home ft distancing Clean your as much as (remaining at hands often possible least 6 feet away from others)

In addition, CDC also recommends that everyone wear cloth face coverings when leaving their homes, regardless of whether they have fever or symptoms of COVID-19. This is because of evidence that people with COVID-19 can spread the disease, even when they don’t have any symptoms. Cloth face coverings should not be placed on young children under age 2, anyone who has trouble breathing, or is unconscious, incapacitated, or otherwise unable to remove the mask without assistance.

How cloth face coverings work Cloth face coverings may prevent the person wearing the mask from spreading respiratory droplets when talking, sneezing, or coughing. If everyone wears a cloth face covering when out in public, such as going to the grocery store, the risk of exposure to SARS-CoV-2 can be reduced for the community. Since people may spread the virus before symptoms start, or even if people never have symptoms, wearing a cloth face covering may protect others around you. Face coverings worn by others may protect you from getting the virus from people carrying the virus.

General considerations for the use of cloth face coverings When using a cloth face covering, make sure: • The mouth and nose are fully covered • The covering fits snugly against the Wash your cloth face covering after sides of the face so there are no gaps each use in the washing machine • You do not have any difficulty or by hand using a bleach solution. breathing while wearing the cloth Allow it to completely dry. face covering • The cloth face covering can be tied or otherwise secured to prevent slipping

For more information, go to: https://wwwdev.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-to-make-cloth-face-covering.html

cdc.gov/coronavirus

CS 316651-A 05/22/2020 Symptoms of Coronavirus (COVID-19)

Know the symptoms of COVID-19, which can include the following:

Cough Fever Chills Muscle pain

Shortness of breath or Sore throat New loss of difficulty breathing* taste or smell

Symptoms can range from mild to severe illness, and appear 2-14 days after you are exposed to the virus that causes COVID-19.

*Seek medical care immediately if someone has emergency warning signs of COVID-19.

• Trouble breathing • Inability to wake or • Persistent pain or pressure stay awake in the chest • Bluish lips or face • New confusion

This list is not all possible symptoms. Please call your medical provider for any other symptoms that are severe or concerning to you.

cdc.gov/coronavirus

317142-A May 20, 2020 10:44 AM HEALTH ALERT: Coronavirus Disease 2019 (COVID-19) You have traveled internationally and are at higher risk. COVID-19 is a respiratory illness that can spread from person to person.

Stay Home Symptoms • Stay home for the next 14 days, monitor your health, and Illnesses have ranged from mild symptoms to severe practice social distancing. illness and death. Symptoms may appear 2–14 days • Take your temperature with a thermometer two times a day after exposure. and watch for symptoms. • Avoid contact with others. Do not go to work or school. • Keep your distance from others (about 6 feet or 2 meters). Symptoms can include:

If you feel sick and have symptoms: Fever • Stay home. Avoid contact with others. • You might have COVID-19; most people are able to recover at home Cough without medical care. • If you have trouble breathing or are worried about your symptoms, call or text a healthcare provider. Tell them about your recent travel Trouble breathing and your symptoms. • Call ahead before you go to a doctor’s office or emergency room.

Visit the website for more information on monitoring your health and how to contact local public health officials. Visit: www.cdc.gov/COVIDtravel CS 315649-B March 24, 2020 1:40 PM Open your cell phone camera and scan this code for information on COVID-19, areas affected, and how to monitor your health after travel.

www.cdc.gov/COVIDtravel

Please read before entering. IF YOU HAVE

Cough Fever

Shortness of breath

Please call our office before coming inside. Clinic Phone #

The clinic staff may ask you to wear a mask or use tissues to cover your cough. Thank you for helping us keep our patients and staff safe.

For more information: www.cdc.gov/COVID19

CS 315889-B 03/12/2020 How to Protect Yourself and Others Know how it spreads • There is currently no vaccine to prevent coronavirus disease 2019 (COVID-19). • The best way to prevent illness is to avoid being exposed to this virus. • The virus is thought to spread mainly from person-to-person. » Between people who are in close contact with one another (within about 6 feet). » Through respiratory droplets produced when an infected person coughs, sneezes or talks. » These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs. » Some recent studies have suggested that COVID-19 may be spread by people who are not showing symptoms. Everyone should Clean your hands often • Wash your hands often with soap and water for at least 20 seconds especially after you have been in a public place, or after blowing your nose, coughing, or sneezing. • If soap and water are not readily available, use a hand sanitizer that contains at least 60% alcohol. Cover all surfaces of your hands and rub them together until they feel dry. • Avoid touching your eyes, nose, and mouth with unwashed hands.

Avoid close contact • Stay home if you are sick. • Avoid close contact with people who are sick. • Put distance between yourself and other people. » Remember that some people without symptoms may be able to spread virus. » This is especially important for people who are at higher risk of getting very sick. www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people- at-higher-risk.html

cdc.gov/coronavirus

CS 316291A 05/05/2020 Cover your mouth and nose with a cloth face cover when around others • You could spread COVID-19 to others even if you do not feel sick. • Everyone should wear a cloth face cover when they have to go out in public, for example to the grocery store or to pick up other necessities. » Cloth face coverings should not be placed on young children under age 2, anyone who has trouble breathing, or is unconscious, incapacitated or otherwise unable to remove the mask without assistance. • The cloth face cover is meant to protect other people in case you are infected. • Do NOT use a facemask meant for a healthcare worker. • Continue to keep about 6 feet between yourself and others. The cloth face cover is not a substitute for social distancing.

Cover coughs and sneezes • If you are in a private setting and do not have on your cloth face covering, remember to always cover your mouth and nose with a tissue when you cough or sneeze or use the inside of your elbow. • Throw used tissues in the trash. • Immediately wash your hands with soap and water for at least 20 seconds. If soap and water are not readily available, clean your hands with a hand sanitizer that contains at least 60% alcohol.

Clean and disinfect • Clean AND disinfect frequently touched surfaces daily. This includes tables, doorknobs, light switches, countertops, handles, desks, phones, keyboards, toilets, faucets, and sinks. www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/ disinfecting-your-home.html • If surfaces are dirty, clean them: Use detergent or soap and water prior to disinfection. • Then, use a household disinfectant. You can see a list of EPA-registered household disinfectants here.

cdc.gov/coronavirus Share facts about COVID-19 Know the facts about coronavirus (COVID-19) and help stop the spread of rumors.

FACT Diseases can make anyone FACT There are simple things you can do to sick regardless of their race help keep yourself and others healthy. 1 or ethnicity. 4 Fear and anxiety about COVID-19 can • Wash your hands often with soap and water cause people to avoid or reject others for at least 20 seconds, especially after blowing even though they are not at risk for your nose, coughing, or sneezing; going to the spreading the virus. bathroom; and before eating or preparing food. • When in public, wear a cloth face covering that covers your mouth and nose. For most people, the FACT • Avoid touching your eyes, nose, and mouth with immediate risk of becoming unwashed hands. 2 seriously ill from the virus that causes COVID-19 is • Stay home when you are sick. thought to be low. • Cover your cough or sneeze with a tissue, then throw the tissue in the trash. Older adults and people of any age who have serious underlying medical conditions may be at higher risk for more serious FACT You can help stop COVID-19 by complications from COVID-19. knowing the signs and symptoms, 5 which can include: • Fever FACT Someone who has • Cough completed quarantine or • Shortness of breath 3 has been released from Seek medical attention immediately if you or isolation does not pose a someone you love has emergency warning signs, risk of infection to including: other people. • Trouble breathing For up-to-date information, visit CDC’s • Persistent pain or pressure in the chest coronavirus disease 2019 web page. • New confusion or not able to be woken • Bluish lips or face This list is not all inclusive. Please consult your medical provider for any other symptoms that are severe or concerning.

cdc.gov/coronavirus CS 316439-A 04/14/2020 Prevent the spread of COVID-19 if you are sick Accessible version: https://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/steps-when-sick.html

If you are sick with COVID-19 or think you might If you develop emergency warning signs for COVID-19 get have COVID-19, follow the steps below to help medical attention immediately. protect other people in your home and community. Emergency warning signs include*: • Trouble breathing • Persistent pain or pressure in the chest Stay home except to get medical care. • New confusion or not able to be woken • Stay home. Most people with COVID-19 • Bluish lips or face have mild illness and are able to recover at home without medical care. Do not leave *This list is not all inclusive. Please consult your medical your home, except to get medical care. Do provider for any other symptoms that are severe or concerning not visit public areas. to you. • Take care of yourself. Get rest and stay hydrated. Call 911 if you have a medical emergency. If you have a • Get medical care when needed. Call your doctor before medical emergency and need to call 911, notify the operator you go to their office for care. But, if you have trouble that you have or think you might have, COVID-19. If possible, breathing or other concerning symptoms, call 911 for put on a facemask before medical help arrives. immediate help. • Avoid public transportation, ride-sharing, or taxis. Call ahead before visiting your doctor. Separate yourself from other people and • Call ahead. Many medical visits for routine pets in your home. care are being postponed or done by phone or telemedicine. • As much as possible, stay in a specific roomand away from other people and pets in your • If you have a medical appointment that cannot be postponed, call your home. Also, you should use a separate doctor’s office.This will help the office protect themselves and bathroom, if available. If you need to be around other other patients. people or animals in or outside of the home, wear a cloth face covering. If you are sick, wear a cloth covering over ɞ See COVID-19 and Animals if you have questions your nose and mouth. about pets: https://www.cdc.gov/coronavirus/2019- • You should wear a cloth face covering over your ncov/faq.html#COVID19animals nose and mouth if you must be around other people or animals, including pets (even Monitor your symptoms. at home). • Common symptoms of COVID-19 include fever and cough. Trouble breathing is a more serious • You don’t need to wear the cloth face covering if you are alone. symptom that means you should get If you can’t put on a cloth face covering (because of trouble medical attention. breathing for example), cover your coughs and sneezes in some other way. Try to stay at least 6 feet away from other people. • Follow care instructions from your healthcare provider and This will help protect the people around you. local health department. Your local health authorities Note: During the COVID-19 pandemic, medical grade facemasks will give instructions on checking your symptoms are reserved for healthcare workers and some first responders. and reporting information. You may need to make a cloth face covering using a scarf or bandana.

cdc.gov/coronavirus

CS 316120-A 05/03/2020 Cover your coughs and sneezes. • Use household cleaners and disinfectants. Clean the area or item with soap and water or another detergent if it is dirty. Then • Cover your mouth and nose with a tissue when use a household disinfectant. you cough or sneeze. ɞ Be sure to follow the instructions on the label to ensure • Throw used tissues in a lined trash can. safe and effective use of the product. Many products • Immediately wash your hands with soap and water for at least recommend keeping the surface wet for several minutes 20 seconds. If soap and water are not available, clean your to ensure germs are killed. Many also recommend hands with an alcohol-based hand sanitizer that contains at precautions such as wearing gloves and making sure you least 60% alcohol. have good ventilation during use of the product.

Clean your hands often. ɞ Most EPA-registered household disinfectants should be effective. • Wash your hands often with soap and water for at least 20 seconds. This is especially How to discontinue home isolation important after blowing your nose, • People with COVID-19 who have stayed home coughing, or sneezing; going to the (home isolated) can stop home isolation bathroom; and before eating or under the following conditions: preparing food. ɞ If you will not have a test to determine if you are still Use hand sanitizer • if soap and water are not available. Use contagious, you can leave home after an alcohol-based hand sanitizer with at least 60% alcohol, these three things have happened: covering all surfaces of your hands and rubbing them together until they feel dry. § You have had no fever for at least 72 hours (that is three full days of no fever without the use of • Soap and water are the best option, especially if your hands medicine that reduces fevers) are visibly dirty. AND • Avoid touching your eyes, nose, and mouth with unwashed hands. § other symptoms have improved (for example, when your cough or shortness of breath has improved) Avoid sharing personal household items. AND • Do not share dishes, drinking glasses, cups, eating utensils, towels, or bedding with § at least 10 days have passed since your symptoms other people in your home. first appeared. • Wash these items thoroughly after using them with soap and ɞ If you will be tested to determine if you are still water or put them in the dishwasher. contagious, you can leave home after these three things have happened: Clean all “high-touch” surfaces everyday. § You no longer have a fever (without the use • Clean and disinfect high-touch surfaces of medicine that reduces fevers) in your “sick room” and bathroom. Let someone else clean and disinfect surfaces AND in common areas, but not your bedroom and bathroom. § other symptoms have improved (for example, when your cough or shortness of breath has improved) • If a caregiver or other person needs to clean and disinfect a sick person’s bedroom or bathroom, they should do so on an AND as-needed basis. The caregiver/other person should wear a mask and wait as long as possible after the sick person has § you received two negative tests in a row, 24 hours used the bathroom. apart. Your doctor will follow CDC guidelines. High-touch surfaces include phones, remote controls, counters, tabletops, doorknobs, bathroom fixtures, toilets, keyboards, In all cases, follow the guidance of your healthcare provider and local health tablets, and bedside tables. department. The decision to stop home isolation should be made • Clean and disinfect areas that may have blood, stool, or body fluids in consultation with your healthcare provider and state and local on them. health departments. Local decisions depend on local circumstances. Stop the Spread of Germs

Help prevent the spread of respiratory diseases like COVID-19. 6 ft

Stay at least 6 feet Cover your cough or sneeze with a (about 2 arms’ length) tissue, then throw the tissue in the from other people. trash and wash your hands.

When in public, wear a Clean and disinfect Do not touch your cloth face covering over frequently touched eyes, nose, and mouth. your nose and mouth. objects and surfaces.

Stay home when you are sick, Wash your hands often with soap except to get medical care. and water for at least 20 seconds.

cdc.gov/coronavirus

316917-A May 13, 2020 11:00 AM If you have theseIf you symptoms, have these symptoms, please please see thesee front the deskfront immediately. desk immediately.

Patients with COVID-19 may have these symptoms:

Cough Fever

Shortness of breath

We may ask you to wear a mask or use tissues to cover your cough, and offer you a separate space to wait.

Thank you for helping us protect other patients and staff.

For more information: cdc.gov/COVID19

315894 March 13, 2020 12:06 PM Hands that look clean can still have icky germs!

Wash Your Hands!

This material was developed by CDC. The Life is Better with Clean Hands campaign is made possible by a partnership between the CDC Foundation, GOJO, and Staples. HHS/CDC does not endorse commercial products, services, or companies.